id	sid	tid	token	lemma	pos
ct-10135	1	1	2011	2011	NUM
ct-10135	1	2	:	:	PUNCT
ct-10135	1	3	efficacy	efficacy	NOUN
ct-10135	1	4	of	of	ADP
ct-10135	1	5	lyophilized	lyophilized	ADJ
ct-10135	1	6	deslorelin	deslorelin	NOUN
ct-10135	1	7	on	on	ADP
ct-10135	1	8	induction	induction	NOUN
ct-10135	1	9	of	of	ADP
ct-10135	1	10	ovulation	ovulation	NOUN
ct-10135	1	11	in	in	ADP
ct-10135	1	12	mares	mare	NOUN
ct-10135	1	13	efficacy	efficacy	NOUN
ct-10135	1	14	of	of	ADP
ct-10135	1	15	lyophilized	lyophilized	ADJ
ct-10135	1	16	deslorelin	deslorelin	NOUN
ct-10135	1	17	on	on	ADP
ct-10135	1	18	induction	induction	NOUN
ct-10135	1	19	of	of	ADP
ct-10135	1	20	ovulation	ovulation	NOUN
ct-10135	1	21	in	in	ADP
ct-10135	1	22	mares	mare	NOUN
ct-10135	1	23	ryan	ryan	PROPN
ct-10135	1	24	a.	a.	PROPN
ct-10135	1	25	ferris	ferris	PROPN
ct-10135	1	26	,	,	PUNCT
ct-10135	1	27	alicia	alicia	PROPN
ct-10135	1	28	r.g	r.g	PROPN
ct-10135	1	29	.	.	PROPN
ct-10135	1	30	lindholm	lindholm	PROPN
ct-10135	1	31	,	,	PUNCT
ct-10135	1	32	david	david	PROPN
ct-10135	1	33	b.	b.	PROPN
ct-10135	1	34	scofield	scofield	PROPN
ct-10135	1	35	,	,	PUNCT
ct-10135	1	36	patrick	patrick	PROPN
ct-10135	1	37	m.	m.	PROPN
ct-10135	1	38	mccue	mccue	PROPN
ct-10135	1	39	equine	equine	PROPN
ct-10135	1	40	reproduction	reproduction	NOUN
ct-10135	1	41	laboratory	laboratory	NOUN
ct-10135	1	42	,	,	PUNCT
ct-10135	1	43	colorado	colorado	PROPN
ct-10135	1	44	state	state	PROPN
ct-10135	1	45	university	university	PROPN
ct-10135	1	46	,	,	PUNCT
ct-10135	1	47	fort	fort	PROPN
ct-10135	1	48	collins	collins	PROPN
ct-10135	1	49	,	,	PUNCT
ct-10135	1	50	co	co	VERB
ct-10135	1	51	abstract	abstract	ADJ
ct-10135	1	52	options	option	NOUN
ct-10135	1	53	for	for	ADP
ct-10135	1	54	induction	induction	NOUN
ct-10135	1	55	of	of	ADP
ct-10135	1	56	ovulation	ovulation	NOUN
ct-10135	1	57	in	in	ADP
ct-10135	1	58	mares	mare	NOUN
ct-10135	1	59	include	include	VERB
ct-10135	1	60	human	human	ADJ
ct-10135	1	61	chorionic	chorionic	ADJ
ct-10135	1	62	gonadotropin	gonadotropin	NOUN
ct-10135	1	63	(	(	PUNCT
ct-10135	1	64	hcg	hcg	PROPN
ct-10135	1	65	)	)	PUNCT
ct-10135	1	66	and	and	CCONJ
ct-10135	1	67	potent	potent	ADJ
ct-10135	1	68	agonists	agonist	NOUN
ct-10135	1	69	of	of	ADP
ct-10135	1	70	gonadotropin	gonadotropin	NOUN
ct-10135	1	71	-	-	PUNCT
ct-10135	1	72	releasing	release	VERB
ct-10135	1	73	hormone	hormone	NOUN
ct-10135	1	74	(	(	PUNCT
ct-10135	1	75	gnrh	gnrh	NOUN
ct-10135	1	76	)	)	PUNCT
ct-10135	1	77	such	such	ADJ
ct-10135	1	78	as	as	ADP
ct-10135	1	79	deslorelin	deslorelin	NOUN
ct-10135	1	80	acetate	acetate	NOUN
ct-10135	1	81	.	.	PUNCT
ct-10135	2	1	when	when	SCONJ
ct-10135	2	2	no	no	DET
ct-10135	2	3	commercially	commercially	ADV
ct-10135	2	4	produced	produce	VERB
ct-10135	2	5	gnrh	gnrh	NOUN
ct-10135	2	6	agonists	agonist	NOUN
ct-10135	2	7	are	be	AUX
ct-10135	2	8	available	available	ADJ
ct-10135	2	9	,	,	PUNCT
ct-10135	2	10	gnrh	gnrh	NOUN
ct-10135	2	11	agonists	agonist	NOUN
ct-10135	2	12	can	can	AUX
ct-10135	2	13	be	be	AUX
ct-10135	2	14	acquired	acquire	VERB
ct-10135	2	15	through	through	ADP
ct-10135	2	16	compounding	compound	VERB
ct-10135	2	17	pharmacies	pharmacy	NOUN
ct-10135	2	18	.	.	PUNCT
ct-10135	3	1	the	the	DET
ct-10135	3	2	objective	objective	NOUN
ct-10135	3	3	of	of	ADP
ct-10135	3	4	this	this	DET
ct-10135	3	5	project	project	NOUN
ct-10135	3	6	was	be	AUX
ct-10135	3	7	to	to	PART
ct-10135	3	8	evaluate	evaluate	VERB
ct-10135	3	9	the	the	DET
ct-10135	3	10	efficacy	efficacy	NOUN
ct-10135	3	11	of	of	ADP
ct-10135	3	12	lyophilized	lyophilized	ADJ
ct-10135	3	13	deslorelin	deslorelin	NOUN
ct-10135	3	14	acetate	acetate	NOUN
ct-10135	3	15	to	to	PART
ct-10135	3	16	induce	induce	VERB
ct-10135	3	17	ovulation	ovulation	NOUN
ct-10135	3	18	and	and	CCONJ
ct-10135	3	19	to	to	PART
ct-10135	3	20	determine	determine	VERB
ct-10135	3	21	if	if	SCONJ
ct-10135	3	22	the	the	DET
ct-10135	3	23	efficacy	efficacy	NOUN
ct-10135	3	24	was	be	AUX
ct-10135	3	25	adversely	adversely	ADV
ct-10135	3	26	affected	affect	VERB
ct-10135	3	27	after	after	ADP
ct-10135	3	28	12	12	NUM
ct-10135	3	29	months	month	NOUN
ct-10135	3	30	of	of	ADP
ct-10135	3	31	storage	storage	NOUN
ct-10135	3	32	.	.	PUNCT
ct-10135	4	1	mares	mare	NOUN
ct-10135	4	2	in	in	ADP
ct-10135	4	3	estrus	estrus	NOUN
ct-10135	4	4	were	be	AUX
ct-10135	4	5	administered	administer	VERB
ct-10135	4	6	1.5	1.5	NUM
ct-10135	4	7	mg	mg	NOUN
ct-10135	4	8	of	of	ADP
ct-10135	4	9	deslorelin	deslorelin	NOUN
ct-10135	4	10	(	(	PUNCT
ct-10135	4	11	lyophilized2009	lyophilized2009	PROPN
ct-10135	4	12	,	,	PUNCT
ct-10135	4	13	lyophilized2010	lyophilized2010	PROPN
ct-10135	4	14	,	,	PUNCT
ct-10135	4	15	or	or	CCONJ
ct-10135	4	16	aqueous	aqueous	ADJ
ct-10135	4	17	deslorelin	deslorelin	NOUN
ct-10135	4	18	)	)	PUNCT
ct-10135	4	19	as	as	ADP
ct-10135	4	20	an	an	DET
ct-10135	4	21	intramuscular	intramuscular	ADJ
ct-10135	4	22	injection	injection	NOUN
ct-10135	4	23	once	once	SCONJ
ct-10135	4	24	a	a	DET
ct-10135	4	25	follicle	follicle	NOUN
ct-10135	4	26			NUM
ct-10135	4	27	35	35	NUM
ct-10135	4	28	mm	mm	NOUN
ct-10135	4	29	was	be	AUX
ct-10135	4	30	detected	detect	VERB
ct-10135	4	31	in	in	ADP
ct-10135	4	32	the	the	DET
ct-10135	4	33	presence	presence	NOUN
ct-10135	4	34	of	of	ADP
ct-10135	4	35	uterine	uterine	ADJ
ct-10135	4	36	edema	edema	NOUN
ct-10135	4	37	.	.	PUNCT
ct-10135	5	1	mares	mare	NOUN
ct-10135	5	2	were	be	AUX
ct-10135	5	3	subsequently	subsequently	ADV
ct-10135	5	4	examined	examine	VERB
ct-10135	5	5	once	once	ADV
ct-10135	5	6	per	per	ADP
ct-10135	5	7	day	day	NOUN
ct-10135	5	8	to	to	PART
ct-10135	5	9	determine	determine	VERB
ct-10135	5	10	the	the	DET
ct-10135	5	11	day	day	NOUN
ct-10135	5	12	of	of	ADP
ct-10135	5	13	ovulation	ovulation	NOUN
ct-10135	5	14	.	.	PUNCT
ct-10135	6	1	a	a	DET
ct-10135	6	2	total	total	NOUN
ct-10135	6	3	of	of	ADP
ct-10135	6	4	66	66	NUM
ct-10135	6	5	mares	mare	NOUN
ct-10135	6	6	were	be	AUX
ct-10135	6	7	administered	administer	VERB
ct-10135	6	8	lyophilized	lyophilized	ADJ
ct-10135	6	9	deslorelin	deslorelin	NOUN
ct-10135	6	10	in	in	ADP
ct-10135	6	11	2009	2009	NUM
ct-10135	6	12	and	and	CCONJ
ct-10135	6	13	135	135	NUM
ct-10135	6	14	mares	mare	NOUN
ct-10135	6	15	were	be	AUX
ct-10135	6	16	treated	treat	VERB
ct-10135	6	17	in	in	ADP
ct-10135	6	18	2010	2010	NUM
ct-10135	6	19	with	with	ADP
ct-10135	6	20	lyophilized	lyophilized	ADJ
ct-10135	6	21	deslorelin	deslorelin	NOUN
ct-10135	6	22	from	from	ADP
ct-10135	6	23	the	the	DET
ct-10135	6	24	same	same	ADJ
ct-10135	6	25	initial	initial	ADJ
ct-10135	6	26	lot	lot	NOUN
ct-10135	6	27	stored	store	VERB
ct-10135	6	28	for	for	ADP
ct-10135	6	29	12	12	NUM
ct-10135	6	30	months	month	NOUN
ct-10135	6	31	.	.	PUNCT
ct-10135	7	1	thirty	thirty	NUM
ct-10135	7	2	mares	mare	NOUN
ct-10135	7	3	were	be	AUX
ct-10135	7	4	administered	administer	VERB
ct-10135	7	5	liquid	liquid	ADJ
ct-10135	7	6	suspension	suspension	NOUN
ct-10135	7	7	deslorelin	deslorelin	NOUN
ct-10135	7	8	in	in	ADP
ct-10135	7	9	2010	2010	NUM
ct-10135	7	10	.	.	PUNCT
ct-10135	8	1	there	there	PRON
ct-10135	8	2	was	be	VERB
ct-10135	8	3	no	no	DET
ct-10135	8	4	significant	significant	ADJ
ct-10135	8	5	difference	difference	NOUN
ct-10135	8	6	in	in	ADP
ct-10135	8	7	mean	mean	ADJ
ct-10135	8	8	days	day	NOUN
ct-10135	8	9	to	to	ADP
ct-10135	8	10	ovulation	ovulation	NOUN
ct-10135	8	11	among	among	ADP
ct-10135	8	12	treatment	treatment	NOUN
ct-10135	8	13	groups	group	NOUN
ct-10135	8	14	with	with	ADP
ct-10135	8	15	majority	majority	NOUN
ct-10135	8	16	of	of	ADP
ct-10135	8	17	treated	treat	VERB
ct-10135	8	18	mares	mare	NOUN
ct-10135	8	19	(	(	PUNCT
ct-10135	8	20	89.6	89.6	NUM
ct-10135	8	21	%	%	NOUN
ct-10135	8	22	)	)	PUNCT
ct-10135	8	23	ovulating	ovulate	VERB
ct-10135	8	24	within	within	ADP
ct-10135	8	25	48	48	NUM
ct-10135	8	26	hours	hour	NOUN
ct-10135	8	27	after	after	ADP
ct-10135	8	28	deslorelin	deslorelin	NOUN
ct-10135	8	29	administration	administration	NOUN
ct-10135	8	30	.	.	PUNCT
ct-10135	9	1	results	result	NOUN
ct-10135	9	2	of	of	ADP
ct-10135	9	3	this	this	DET
ct-10135	9	4	study	study	NOUN
ct-10135	9	5	indicate	indicate	VERB
ct-10135	9	6	that	that	SCONJ
ct-10135	9	7	lyophilized	lyophilized	ADJ
ct-10135	9	8	deslorelin	deslorelin	NOUN
ct-10135	9	9	stored	store	VERB
ct-10135	9	10	for	for	ADP
ct-10135	9	11	12	12	NUM
ct-10135	9	12	months	month	NOUN
ct-10135	9	13	,	,	PUNCT
ct-10135	9	14	reconstituted	reconstitute	VERB
ct-10135	9	15	in	in	ADP
ct-10135	9	16	sterile	sterile	ADJ
ct-10135	9	17	saline	saline	NOUN
ct-10135	9	18	,	,	PUNCT
ct-10135	9	19	is	be	AUX
ct-10135	9	20	equally	equally	ADV
ct-10135	9	21	as	as	ADV
ct-10135	9	22	effective	effective	ADJ
ct-10135	9	23	at	at	ADP
ct-10135	9	24	inducing	induce	VERB
ct-10135	9	25	a	a	DET
ct-10135	9	26	timed	time	VERB
ct-10135	9	27	ovulation	ovulation	NOUN
ct-10135	9	28	in	in	ADP
ct-10135	9	29	estrual	estrual	ADJ
ct-10135	9	30	mares	mare	NOUN
ct-10135	9	31	as	as	ADP
ct-10135	9	32	deslorelin	deslorelin	NOUN
ct-10135	9	33	in	in	ADP
ct-10135	9	34	a	a	DET
ct-10135	9	35	liquid	liquid	ADJ
ct-10135	9	36	suspension	suspension	NOUN
ct-10135	9	37	.	.	PUNCT
ct-10135	10	1	in	in	ADP
ct-10135	10	2	conclusion	conclusion	NOUN
ct-10135	10	3	,	,	PUNCT
ct-10135	10	4	non	non	ADJ
ct-10135	10	5	-	-	ADJ
ct-10135	10	6	reconstituted	reconstituted	ADJ
ct-10135	10	7	vials	vial	NOUN
ct-10135	10	8	of	of	ADP
ct-10135	10	9	lyophilized	lyophilized	ADJ
ct-10135	10	10	deslorelin	deslorelin	NOUN
ct-10135	10	11	may	may	AUX
ct-10135	10	12	be	be	AUX
ct-10135	10	13	stored	store	VERB
ct-10135	10	14	for	for	ADP
ct-10135	10	15	at	at	ADV
ct-10135	10	16	least	least	ADV
ct-10135	10	17	12	12	NUM
ct-10135	10	18	months	month	NOUN
ct-10135	10	19	without	without	ADP
ct-10135	10	20	a	a	DET
ct-10135	10	21	significant	significant	ADJ
ct-10135	10	22	loss	loss	NOUN
ct-10135	10	23	in	in	ADP
ct-10135	10	24	efficacy	efficacy	NOUN
ct-10135	10	25	.	.	PUNCT
ct-10135	11	1	keywords	keyword	NOUN
ct-10135	11	2	:	:	PUNCT
ct-10135	11	3	ovulation	ovulation	NOUN
ct-10135	11	4	,	,	PUNCT
ct-10135	11	5	induction	induction	NOUN
ct-10135	11	6	,	,	PUNCT
ct-10135	11	7	mare	mare	NOUN
ct-10135	11	8	,	,	PUNCT
ct-10135	11	9	deslorelin	deslorelin	NOUN
ct-10135	11	10	,	,	PUNCT
ct-10135	11	11	gnrh	gnrh	NOUN
ct-10135	11	12	agonist	agonist	NOUN
ct-10135	11	13	introduction	introduction	NOUN
ct-10135	11	14	options	option	NOUN
ct-10135	11	15	for	for	ADP
ct-10135	11	16	induction	induction	NOUN
ct-10135	11	17	of	of	ADP
ct-10135	11	18	ovulation	ovulation	NOUN
ct-10135	11	19	in	in	ADP
ct-10135	11	20	mares	mare	NOUN
ct-10135	11	21	include	include	VERB
ct-10135	11	22	hcg	hcg	PROPN
ct-10135	11	23	and	and	CCONJ
ct-10135	11	24	potent	potent	ADJ
ct-10135	11	25	agonists	agonist	NOUN
ct-10135	11	26	of	of	ADP
ct-10135	11	27	gnrh	gnrh	NOUN
ct-10135	11	28	such	such	ADJ
ct-10135	11	29	as	as	ADP
ct-10135	11	30	deslorelin	deslorelin	NOUN
ct-10135	11	31	acetate.1	acetate.1	X
ct-10135	11	32	-	-	PUNCT
ct-10135	11	33	3	3	NUM
ct-10135	11	34	deslorelin	deslorelin	NOUN
ct-10135	11	35	and	and	CCONJ
ct-10135	11	36	hcg	hcg	PROPN
ct-10135	11	37	are	be	AUX
ct-10135	11	38	equally	equally	ADV
ct-10135	11	39	effective	effective	ADJ
ct-10135	11	40	in	in	ADP
ct-10135	11	41	inducing	induce	VERB
ct-10135	11	42	a	a	DET
ct-10135	11	43	timed	time	VERB
ct-10135	11	44	ovulation	ovulation	NOUN
ct-10135	11	45	when	when	SCONJ
ct-10135	11	46	administered	administer	VERB
ct-10135	11	47	to	to	ADP
ct-10135	11	48	mares	mare	NOUN
ct-10135	11	49	in	in	ADP
ct-10135	11	50	estrus	estrus	NOUN
ct-10135	11	51	with	with	ADP
ct-10135	11	52	a	a	DET
ct-10135	11	53	follicle	follicle	NOUN
ct-10135	11	54			NUM
ct-10135	11	55	35	35	NUM
ct-10135	11	56	mm	mm	NOUN
ct-10135	11	57	in	in	ADP
ct-10135	11	58	diameter.4	diameter.4	PROPN
ct-10135	11	59	the	the	DET
ct-10135	11	60	interval	interval	NOUN
ct-10135	11	61	from	from	ADP
ct-10135	11	62	administration	administration	NOUN
ct-10135	11	63	to	to	ADP
ct-10135	11	64	ovulation	ovulation	NOUN
ct-10135	11	65	has	have	AUX
ct-10135	11	66	been	be	AUX
ct-10135	11	67	reported	report	VERB
ct-10135	11	68	to	to	PART
ct-10135	11	69	be	be	AUX
ct-10135	11	70	approximately	approximately	ADV
ct-10135	11	71	36	36	NUM
ct-10135	11	72	hours	hour	NOUN
ct-10135	11	73	for	for	ADP
ct-10135	11	74	hcg	hcg	PROPN
ct-10135	11	75	and	and	CCONJ
ct-10135	11	76	40	40	NUM
ct-10135	11	77	hours	hour	NOUN
ct-10135	11	78	for	for	ADP
ct-10135	11	79	deslorelin.5	deslorelin.5	NOUN
ct-10135	11	80	one	one	NUM
ct-10135	11	81	advantage	advantage	NOUN
ct-10135	11	82	of	of	ADP
ct-10135	11	83	deslorelin	deslorelin	NOUN
ct-10135	11	84	is	be	AUX
ct-10135	11	85	that	that	DET
ct-10135	11	86	efficacy	efficacy	NOUN
ct-10135	11	87	in	in	ADP
ct-10135	11	88	inducing	induce	VERB
ct-10135	11	89	a	a	DET
ct-10135	11	90	timed	time	VERB
ct-10135	11	91	ovulation	ovulation	NOUN
ct-10135	11	92	is	be	AUX
ct-10135	11	93	not	not	PART
ct-10135	11	94	reduced	reduce	VERB
ct-10135	11	95	after	after	SCONJ
ct-10135	11	96	multiple	multiple	ADJ
ct-10135	11	97	doses	dose	NOUN
ct-10135	11	98	are	be	AUX
ct-10135	11	99	administered	administer	VERB
ct-10135	11	100	during	during	ADP
ct-10135	11	101	a	a	DET
ct-10135	11	102	single	single	ADJ
ct-10135	11	103	breeding	breeding	NOUN
ct-10135	11	104	season.6	season.6	NOUN
ct-10135	11	105	in	in	ADP
ct-10135	11	106	contrast	contrast	NOUN
ct-10135	11	107	,	,	PUNCT
ct-10135	11	108	efficacy	efficacy	NOUN
ct-10135	11	109	of	of	ADP
ct-10135	11	110	hcg	hcg	PROPN
ct-10135	11	111	has	have	AUX
ct-10135	11	112	been	be	AUX
ct-10135	11	113	reported	report	VERB
ct-10135	11	114	to	to	PART
ct-10135	11	115	decrease	decrease	VERB
ct-10135	11	116	if	if	SCONJ
ct-10135	11	117	used	use	VERB
ct-10135	11	118	multiple	multiple	ADJ
ct-10135	11	119	times	time	NOUN
ct-10135	11	120	in	in	ADP
ct-10135	11	121	a	a	DET
ct-10135	11	122	single	single	ADJ
ct-10135	11	123	breeding	breeding	NOUN
ct-10135	11	124	season.2,3	season.2,3	ADP
ct-10135	11	125	the	the	DET
ct-10135	11	126	implant	implant	ADJ
ct-10135	11	127	version	version	NOUN
ct-10135	11	128	of	of	ADP
ct-10135	11	129	deslorelin	deslorelin	NOUN
ct-10135	11	130	acetate	acetate	NOUN
ct-10135	11	131	(	(	PUNCT
ct-10135	11	132	ovuplant	ovuplant	PROPN
ct-10135	11	133	™	™	PROPN
ct-10135	11	134	,	,	PUNCT
ct-10135	11	135	fort	fort	NOUN
ct-10135	11	136	dodge	dodge	PROPN
ct-10135	11	137	animal	animal	PROPN
ct-10135	11	138	health	health	NOUN
ct-10135	11	139	,	,	PUNCT
ct-10135	11	140	fort	fort	NOUN
ct-10135	11	141	dodge	dodge	PROPN
ct-10135	11	142	,	,	PUNCT
ct-10135	11	143	ia	ia	PROPN
ct-10135	11	144	)	)	PUNCT
ct-10135	11	145	is	be	AUX
ct-10135	11	146	no	no	ADV
ct-10135	11	147	longer	long	ADV
ct-10135	11	148	commercially	commercially	ADV
ct-10135	11	149	available	available	ADJ
ct-10135	11	150	in	in	ADP
ct-10135	11	151	the	the	DET
ct-10135	11	152	united	united	PROPN
ct-10135	11	153	states	states	PROPN
ct-10135	11	154	.	.	PUNCT
ct-10135	12	1	however	however	ADV
ct-10135	12	2	,	,	PUNCT
ct-10135	12	3	the	the	DET
ct-10135	12	4	gnrh	gnrh	NOUN
ct-10135	12	5	agonist	agonist	NOUN
ct-10135	12	6	can	can	AUX
ct-10135	12	7	be	be	AUX
ct-10135	12	8	acquired	acquire	VERB
ct-10135	12	9	through	through	ADP
ct-10135	12	10	a	a	DET
ct-10135	12	11	variety	variety	NOUN
ct-10135	12	12	of	of	ADP
ct-10135	12	13	compounding	compound	VERB
ct-10135	12	14	pharmacies	pharmacy	NOUN
ct-10135	12	15	.	.	PUNCT
ct-10135	13	1	this	this	DET
ct-10135	13	2	project	project	NOUN
ct-10135	13	3	was	be	AUX
ct-10135	13	4	designed	design	VERB
ct-10135	13	5	and	and	CCONJ
ct-10135	13	6	completed	complete	VERB
ct-10135	13	7	prior	prior	ADV
ct-10135	13	8	to	to	ADP
ct-10135	13	9	the	the	DET
ct-10135	13	10	release	release	NOUN
ct-10135	13	11	of	of	ADP
ct-10135	13	12	a	a	DET
ct-10135	13	13	fda	fda	PROPN
ct-10135	13	14	approved	approve	VERB
ct-10135	13	15	deslorelin	deslorelin	NOUN
ct-10135	13	16	product	product	NOUN
ct-10135	13	17	.	.	PUNCT
ct-10135	14	1	the	the	DET
ct-10135	14	2	goals	goal	NOUN
ct-10135	14	3	of	of	ADP
ct-10135	14	4	the	the	DET
ct-10135	14	5	current	current	ADJ
ct-10135	14	6	study	study	NOUN
ct-10135	14	7	were	be	AUX
ct-10135	14	8	to	to	PART
ct-10135	14	9	:	:	PUNCT
ct-10135	14	10	1	1	X
ct-10135	14	11	)	)	PUNCT
ct-10135	14	12	evaluate	evaluate	VERB
ct-10135	14	13	the	the	DET
ct-10135	14	14	efficacy	efficacy	NOUN
ct-10135	14	15	of	of	ADP
ct-10135	14	16	a	a	DET
ct-10135	14	17	lyophilized	lyophilized	ADJ
ct-10135	14	18	deslorelin	deslorelin	NOUN
ct-10135	14	19	preparation	preparation	NOUN
ct-10135	14	20	at	at	ADP
ct-10135	14	21	inducing	induce	VERB
ct-10135	14	22	ovulation	ovulation	NOUN
ct-10135	14	23	and	and	CCONJ
ct-10135	14	24	2	2	NUM
ct-10135	14	25	)	)	PUNCT
ct-10135	14	26	determine	determine	NOUN
ct-10135	14	27	if	if	SCONJ
ct-10135	14	28	lyophilized	lyophilized	ADJ
ct-10135	14	29	deslorelin	deslorelin	NOUN
ct-10135	14	30	could	could	AUX
ct-10135	14	31	be	be	AUX
ct-10135	14	32	stored	store	VERB
ct-10135	14	33	at	at	ADP
ct-10135	14	34	room	room	NOUN
ct-10135	14	35	temperature	temperature	NOUN
ct-10135	14	36	for	for	ADP
ct-10135	14	37	12	12	NUM
ct-10135	14	38	months	month	NOUN
ct-10135	14	39	and	and	CCONJ
ct-10135	14	40	still	still	ADV
ct-10135	14	41	retain	retain	VERB
ct-10135	14	42	clinical	clinical	ADJ
ct-10135	14	43	efficacy	efficacy	NOUN
ct-10135	14	44	.	.	PUNCT
ct-10135	15	1	materials	material	NOUN
ct-10135	15	2	and	and	CCONJ
ct-10135	15	3	methods	method	NOUN
ct-10135	15	4	deslorelin	deslorelin	VERB
ct-10135	15	5	an	an	DET
ct-10135	15	6	allotment	allotment	NOUN
ct-10135	15	7	of	of	ADP
ct-10135	15	8	lyophilized	lyophilized	ADJ
ct-10135	15	9	deslorelin	deslorelin	NOUN
ct-10135	15	10	acetate	acetate	NOUN
ct-10135	15	11	produced	produce	VERB
ct-10135	15	12	in	in	ADP
ct-10135	15	13	a	a	DET
ct-10135	15	14	single	single	ADJ
ct-10135	15	15	lot	lot	NOUN
ct-10135	15	16	was	be	AUX
ct-10135	15	17	acquired	acquire	VERB
ct-10135	15	18	from	from	ADP
ct-10135	15	19	a	a	DET
ct-10135	15	20	compounding	compound	VERB
ct-10135	15	21	pharmacy	pharmacy	NOUN
ct-10135	15	22	(	(	PUNCT
ct-10135	15	23	applied	apply	VERB
ct-10135	15	24	pharmacy	pharmacy	NOUN
ct-10135	15	25	services	service	NOUN
ct-10135	15	26	,	,	PUNCT
ct-10135	15	27	mobile	mobile	NOUN
ct-10135	15	28	,	,	PUNCT
ct-10135	15	29	al	al	PROPN
ct-10135	15	30	)	)	PUNCT
ct-10135	15	31	in	in	ADP
ct-10135	15	32	april	april	PROPN
ct-10135	15	33	2009	2009	NUM
ct-10135	15	34	.	.	PUNCT
ct-10135	16	1	the	the	DET
ct-10135	16	2	allotment	allotment	NOUN
ct-10135	16	3	consisted	consist	VERB
ct-10135	16	4	of	of	ADP
ct-10135	16	5	multiple	multiple	ADJ
ct-10135	16	6	glass	glass	NOUN
ct-10135	16	7	vials	vial	NOUN
ct-10135	16	8	each	each	PRON
ct-10135	16	9	containing	contain	VERB
ct-10135	16	10	15	15	NUM
ct-10135	16	11	mg	mg	NOUN
ct-10135	16	12	of	of	ADP
ct-10135	16	13	lyophilized	lyophilized	ADJ
ct-10135	16	14	deslorelin	deslorelin	NOUN
ct-10135	16	15	acetate	acetate	NOUN
ct-10135	16	16	.	.	PUNCT
ct-10135	17	1	the	the	DET
ct-10135	17	2	shipment	shipment	NOUN
ct-10135	17	3	was	be	AUX
ct-10135	17	4	divided	divide	VERB
ct-10135	17	5	into	into	ADP
ct-10135	17	6	two	two	NUM
ct-10135	17	7	batches	batch	NOUN
ct-10135	17	8	,	,	PUNCT
ct-10135	17	9	one	one	NUM
ct-10135	17	10	batch	batch	NOUN
ct-10135	17	11	was	be	AUX
ct-10135	17	12	used	use	VERB
ct-10135	17	13	beginning	begin	VERB
ct-10135	17	14	in	in	ADP
ct-10135	17	15	april	april	PROPN
ct-10135	17	16	2009	2009	NUM
ct-10135	17	17	for	for	ADP
ct-10135	17	18	the	the	DET
ct-10135	17	19	2009	2009	NUM
ct-10135	17	20	breeding	breeding	NOUN
ct-10135	17	21	season	season	NOUN
ct-10135	17	22	and	and	CCONJ
ct-10135	17	23	the	the	DET
ct-10135	17	24	other	other	ADJ
ct-10135	17	25	batch	batch	NOUN
ct-10135	17	26	was	be	AUX
ct-10135	17	27	stored	store	VERB
ct-10135	17	28	at	at	ADP
ct-10135	17	29	room	room	NOUN
ct-10135	17	30	temperature	temperature	NOUN
ct-10135	17	31	and	and	CCONJ
ct-10135	17	32	used	use	VERB
ct-10135	17	33	beginning	begin	VERB
ct-10135	17	34	in	in	ADP
ct-10135	17	35	april	april	PROPN
ct-10135	17	36	2010	2010	NUM
ct-10135	17	37	for	for	ADP
ct-10135	17	38	the	the	DET
ct-10135	17	39	2010	2010	NUM
ct-10135	17	40	breeding	breeding	NOUN
ct-10135	17	41	season	season	NOUN
ct-10135	17	42	.	.	PUNCT
ct-10135	18	1	individual	individual	ADJ
ct-10135	18	2	vials	vial	NOUN
ct-10135	18	3	of	of	ADP
ct-10135	18	4	deslorelin	deslorelin	NOUN
ct-10135	18	5	were	be	AUX
ct-10135	18	6	reconstituted	reconstitute	VERB
ct-10135	18	7	with	with	ADP
ct-10135	18	8	10	10	NUM
ct-10135	18	9	ml	ml	NOUN
ct-10135	18	10	of	of	ADP
ct-10135	18	11	sterile	sterile	ADJ
ct-10135	18	12	0.9	0.9	NUM
ct-10135	18	13	%	%	NOUN
ct-10135	18	14	saline	saline	NOUN
ct-10135	18	15	as	as	SCONJ
ct-10135	18	16	needed	need	VERB
ct-10135	18	17	to	to	PART
ct-10135	18	18	yield	yield	VERB
ct-10135	18	19	10	10	NUM
ct-10135	18	20	doses	dose	NOUN
ct-10135	18	21	of	of	ADP
ct-10135	18	22	1.5	1.5	NUM
ct-10135	18	23	mg	mg	NOUN
ct-10135	18	24	each	each	PRON
ct-10135	18	25	.	.	PUNCT
ct-10135	19	1	99	99	NUM
ct-10135	19	2	clinical	clinical	ADJ
ct-10135	19	3	theriogenology	theriogenology	NOUN
ct-10135	19	4	•	•	NOUN
ct-10135	19	5	volume	volume	NOUN
ct-10135	19	6	3	3	NUM
ct-10135	19	7	number	number	NOUN
ct-10135	19	8	2	2	NUM
ct-10135	19	9	•	•	NOUN
ct-10135	19	10	june	june	PROPN
ct-10135	19	11	2011	2011	NUM
ct-10135	19	12	a	a	DET
ct-10135	19	13	compounded	compound	VERB
ct-10135	19	14	preparation	preparation	NOUN
ct-10135	19	15	of	of	ADP
ct-10135	19	16	deslorelin	deslorelin	NOUN
ct-10135	19	17	acetate	acetate	NOUN
ct-10135	19	18	in	in	ADP
ct-10135	19	19	aqueous	aqueous	ADJ
ct-10135	19	20	suspension	suspension	NOUN
ct-10135	19	21	(	(	PUNCT
ct-10135	19	22	franck	franck	PROPN
ct-10135	19	23	’s	’s	PART
ct-10135	19	24	pharmacy	pharmacy	NOUN
ct-10135	19	25	,	,	PUNCT
ct-10135	19	26	ocala	ocala	PROPN
ct-10135	19	27	,	,	PUNCT
ct-10135	19	28	fl	fl	PROPN
ct-10135	19	29	)	)	PUNCT
ct-10135	19	30	was	be	AUX
ct-10135	19	31	acquired	acquire	VERB
ct-10135	19	32	in	in	ADP
ct-10135	19	33	april	april	PROPN
ct-10135	19	34	2010	2010	NUM
ct-10135	19	35	for	for	ADP
ct-10135	19	36	comparison	comparison	NOUN
ct-10135	19	37	to	to	ADP
ct-10135	19	38	the	the	DET
ct-10135	19	39	lyophilized	lyophilized	ADJ
ct-10135	19	40	form	form	NOUN
ct-10135	19	41	.	.	PUNCT
ct-10135	20	1	the	the	DET
ct-10135	20	2	dose	dose	NOUN
ct-10135	20	3	of	of	ADP
ct-10135	20	4	liquid	liquid	ADJ
ct-10135	20	5	suspension	suspension	NOUN
ct-10135	20	6	deslorelin	deslorelin	NOUN
ct-10135	20	7	was	be	AUX
ct-10135	20	8	also	also	ADV
ct-10135	20	9	1.5	1.5	NUM
ct-10135	20	10	mg	mg	NOUN
ct-10135	20	11	.	.	PUNCT
ct-10135	21	1	mares	mare	NOUN
ct-10135	21	2	mares	mare	NOUN
ct-10135	21	3	utilized	utilize	VERB
ct-10135	21	4	in	in	ADP
ct-10135	21	5	this	this	DET
ct-10135	21	6	study	study	NOUN
ct-10135	21	7	were	be	AUX
ct-10135	21	8	2	2	NUM
ct-10135	21	9	-	-	SYM
ct-10135	21	10	12	12	NUM
ct-10135	21	11	years	year	NOUN
ct-10135	21	12	of	of	ADP
ct-10135	21	13	age	age	NOUN
ct-10135	21	14	and	and	CCONJ
ct-10135	21	15	were	be	AUX
ct-10135	21	16	of	of	ADP
ct-10135	21	17	light	light	ADJ
ct-10135	21	18	stock	stock	NOUN
ct-10135	21	19	-	-	PUNCT
ct-10135	21	20	type	type	NOUN
ct-10135	21	21	breeds	breed	NOUN
ct-10135	21	22	.	.	PUNCT
ct-10135	22	1	mares	mare	NOUN
ct-10135	22	2	were	be	AUX
ct-10135	22	3	examined	examine	VERB
ct-10135	22	4	by	by	ADP
ct-10135	22	5	transrectal	transrectal	ADJ
ct-10135	22	6	ultrasound	ultrasound	NOUN
ct-10135	22	7	to	to	PART
ct-10135	22	8	monitor	monitor	VERB
ct-10135	22	9	follicular	follicular	ADJ
ct-10135	22	10	development	development	NOUN
ct-10135	22	11	and	and	CCONJ
ct-10135	22	12	the	the	DET
ct-10135	22	13	quantity	quantity	NOUN
ct-10135	22	14	and	and	CCONJ
ct-10135	22	15	degree	degree	NOUN
ct-10135	22	16	of	of	ADP
ct-10135	22	17	uterine	uterine	ADJ
ct-10135	22	18	edema	edema	NOUN
ct-10135	22	19	.	.	PUNCT
ct-10135	23	1	the	the	DET
ct-10135	23	2	diameter	diameter	NOUN
ct-10135	23	3	of	of	ADP
ct-10135	23	4	the	the	DET
ct-10135	23	5	largest	large	ADJ
ct-10135	23	6	follicle	follicle	NOUN
ct-10135	23	7	was	be	AUX
ct-10135	23	8	measured	measure	VERB
ct-10135	23	9	with	with	ADP
ct-10135	23	10	electronic	electronic	ADJ
ct-10135	23	11	calipers	caliper	NOUN
ct-10135	23	12	and	and	CCONJ
ct-10135	23	13	the	the	DET
ct-10135	23	14	edema	edema	NOUN
ct-10135	23	15	score	score	NOUN
ct-10135	23	16	evaluated	evaluate	VERB
ct-10135	23	17	on	on	ADP
ct-10135	23	18	a	a	DET
ct-10135	23	19	scale	scale	NOUN
ct-10135	23	20	of	of	ADP
ct-10135	23	21	0	0	NUM
ct-10135	23	22	to	to	ADP
ct-10135	23	23	3	3	NUM
ct-10135	23	24	,	,	PUNCT
ct-10135	23	25	with	with	ADP
ct-10135	23	26	0	0	NUM
ct-10135	23	27	being	be	AUX
ct-10135	23	28	no	no	DET
ct-10135	23	29	edema	edema	NOUN
ct-10135	23	30	and	and	CCONJ
ct-10135	23	31	3	3	NUM
ct-10135	23	32	being	be	AUX
ct-10135	23	33	maximal	maximal	ADJ
ct-10135	23	34	edema.7	edema.7	NOUN
ct-10135	23	35	once	once	SCONJ
ct-10135	23	36	a	a	DET
ct-10135	23	37	follicle	follicle	NOUN
ct-10135	23	38			NUM
ct-10135	23	39	35	35	NUM
ct-10135	23	40	mm	mm	NOUN
ct-10135	23	41	was	be	AUX
ct-10135	23	42	detected	detect	VERB
ct-10135	23	43	in	in	ADP
ct-10135	23	44	the	the	DET
ct-10135	23	45	presence	presence	NOUN
ct-10135	23	46	of	of	ADP
ct-10135	23	47	uterine	uterine	ADJ
ct-10135	23	48	edema	edema	NOUN
ct-10135	23	49	,	,	PUNCT
ct-10135	23	50	mares	mare	NOUN
ct-10135	23	51	were	be	AUX
ct-10135	23	52	randomly	randomly	ADV
ct-10135	23	53	assigned	assign	VERB
ct-10135	23	54	to	to	PART
ct-10135	23	55	receive	receive	VERB
ct-10135	23	56	1.5	1.5	NUM
ct-10135	23	57	mg	mg	NOUN
ct-10135	23	58	of	of	ADP
ct-10135	23	59	deslorelin	deslorelin	NOUN
ct-10135	23	60	as	as	ADP
ct-10135	23	61	an	an	DET
ct-10135	23	62	intramuscular	intramuscular	ADJ
ct-10135	23	63	injection	injection	NOUN
ct-10135	23	64	.	.	PUNCT
ct-10135	24	1	mares	mare	NOUN
ct-10135	24	2	were	be	AUX
ct-10135	24	3	subsequently	subsequently	ADV
ct-10135	24	4	examined	examine	VERB
ct-10135	24	5	once	once	ADV
ct-10135	24	6	per	per	ADP
ct-10135	24	7	day	day	NOUN
ct-10135	24	8	to	to	PART
ct-10135	24	9	determine	determine	VERB
ct-10135	24	10	the	the	DET
ct-10135	24	11	day	day	NOUN
ct-10135	24	12	of	of	ADP
ct-10135	24	13	ovulation	ovulation	NOUN
ct-10135	24	14	.	.	PUNCT
ct-10135	25	1	statistical	statistical	ADJ
ct-10135	25	2	analysis	analysis	NOUN
ct-10135	25	3	comparison	comparison	NOUN
ct-10135	25	4	of	of	ADP
ct-10135	25	5	follicular	follicular	ADJ
ct-10135	25	6	size	size	NOUN
ct-10135	25	7	at	at	ADP
ct-10135	25	8	the	the	DET
ct-10135	25	9	time	time	NOUN
ct-10135	25	10	of	of	ADP
ct-10135	25	11	treatment	treatment	NOUN
ct-10135	25	12	,	,	PUNCT
ct-10135	25	13	uterine	uterine	ADJ
ct-10135	25	14	edema	edema	NOUN
ct-10135	25	15	at	at	ADP
ct-10135	25	16	the	the	DET
ct-10135	25	17	time	time	NOUN
ct-10135	25	18	of	of	ADP
ct-10135	25	19	treatment	treatment	NOUN
ct-10135	25	20	,	,	PUNCT
ct-10135	25	21	interval	interval	NOUN
ct-10135	25	22	to	to	ADP
ct-10135	25	23	ovulation	ovulation	NOUN
ct-10135	25	24	and	and	CCONJ
ct-10135	25	25	the	the	DET
ct-10135	25	26	percentage	percentage	NOUN
ct-10135	25	27	of	of	ADP
ct-10135	25	28	mares	mare	NOUN
ct-10135	25	29	ovulating	ovulate	VERB
ct-10135	25	30	within	within	ADP
ct-10135	25	31	48	48	NUM
ct-10135	25	32	hours	hour	NOUN
ct-10135	25	33	were	be	AUX
ct-10135	25	34	made	make	VERB
ct-10135	25	35	by	by	ADP
ct-10135	25	36	use	use	NOUN
ct-10135	25	37	of	of	ADP
ct-10135	25	38	a	a	DET
ct-10135	25	39	oneway	oneway	NOUN
ct-10135	25	40	anova	anova	X
ct-10135	25	41	with	with	ADP
ct-10135	25	42	post	post	ADJ
ct-10135	25	43	-	-	ADJ
ct-10135	25	44	hoc	hoc	ADJ
ct-10135	25	45	analysis	analysis	NOUN
ct-10135	25	46	by	by	ADP
ct-10135	25	47	tukey	tukey	PROPN
ct-10135	25	48	’s	’s	PART
ct-10135	25	49	test	test	NOUN
ct-10135	25	50	.	.	PUNCT
ct-10135	26	1	values	value	NOUN
ct-10135	26	2	were	be	AUX
ct-10135	26	3	considered	consider	VERB
ct-10135	26	4	to	to	PART
ct-10135	26	5	be	be	AUX
ct-10135	26	6	statistically	statistically	ADV
ct-10135	26	7	different	different	ADJ
ct-10135	26	8	at	at	ADP
ct-10135	26	9	p	p	X
ct-10135	26	10	<	<	X
ct-10135	26	11	0.05	0.05	NUM
ct-10135	26	12	.	.	PUNCT
ct-10135	27	1	all	all	DET
ct-10135	27	2	data	datum	NOUN
ct-10135	27	3	are	be	AUX
ct-10135	27	4	presented	present	VERB
ct-10135	27	5	as	as	ADP
ct-10135	27	6	the	the	DET
ct-10135	27	7	mean	mean	PROPN
ct-10135	27	8	±	±	NUM
ct-10135	27	9	standard	standard	ADJ
ct-10135	27	10	deviation	deviation	NOUN
ct-10135	27	11	.	.	PUNCT
ct-10135	28	1	results	result	VERB
ct-10135	28	2	a	a	DET
ct-10135	28	3	total	total	NOUN
ct-10135	28	4	of	of	ADP
ct-10135	28	5	66	66	NUM
ct-10135	28	6	mares	mare	NOUN
ct-10135	28	7	received	receive	VERB
ct-10135	28	8	lyophilized	lyophilized	ADJ
ct-10135	28	9	deslorelin	deslorelin	NOUN
ct-10135	28	10	in	in	ADP
ct-10135	28	11	2009	2009	NUM
ct-10135	28	12	and	and	CCONJ
ct-10135	28	13	135	135	NUM
ct-10135	28	14	mares	mare	NOUN
ct-10135	28	15	were	be	AUX
ct-10135	28	16	treated	treat	VERB
ct-10135	28	17	with	with	ADP
ct-10135	28	18	lyophilized	lyophilized	ADJ
ct-10135	28	19	deslorelin	deslorelin	NOUN
ct-10135	28	20	in	in	ADP
ct-10135	28	21	2010	2010	NUM
ct-10135	28	22	from	from	ADP
ct-10135	28	23	the	the	DET
ct-10135	28	24	same	same	ADJ
ct-10135	28	25	initial	initial	ADJ
ct-10135	28	26	lot	lot	NOUN
ct-10135	28	27	and	and	CCONJ
ct-10135	28	28	stored	store	VERB
ct-10135	28	29	for	for	ADP
ct-10135	28	30	12	12	NUM
ct-10135	28	31	months	month	NOUN
ct-10135	28	32	.	.	PUNCT
ct-10135	29	1	thirty	thirty	NUM
ct-10135	29	2	mares	mare	NOUN
ct-10135	29	3	were	be	AUX
ct-10135	29	4	administered	administer	VERB
ct-10135	29	5	liquid	liquid	ADJ
ct-10135	29	6	suspension	suspension	NOUN
ct-10135	29	7	deslorelin	deslorelin	NOUN
ct-10135	29	8	in	in	ADP
ct-10135	29	9	2010	2010	NUM
ct-10135	29	10	.	.	PUNCT
ct-10135	30	1	there	there	PRON
ct-10135	30	2	was	be	VERB
ct-10135	30	3	no	no	DET
ct-10135	30	4	significant	significant	ADJ
ct-10135	30	5	difference	difference	NOUN
ct-10135	30	6	(	(	PUNCT
ct-10135	30	7	p	p	X
ct-10135	30	8	>	>	X
ct-10135	30	9	0.05	0.05	NUM
ct-10135	30	10	)	)	PUNCT
ct-10135	30	11	between	between	ADP
ct-10135	30	12	2009	2009	NUM
ct-10135	30	13	and	and	CCONJ
ct-10135	30	14	2010	2010	NUM
ct-10135	30	15	mares	mare	NOUN
ct-10135	30	16	treated	treat	VERB
ct-10135	30	17	with	with	ADP
ct-10135	30	18	lyophilized	lyophilized	ADJ
ct-10135	30	19	deslorelin	deslorelin	NOUN
ct-10135	30	20	in	in	ADP
ct-10135	30	21	diameter	diameter	NOUN
ct-10135	30	22	of	of	ADP
ct-10135	30	23	the	the	DET
ct-10135	30	24	largest	large	ADJ
ct-10135	30	25	follicle	follicle	NOUN
ct-10135	30	26	or	or	CCONJ
ct-10135	30	27	uterine	uterine	ADJ
ct-10135	30	28	edema	edema	NOUN
ct-10135	30	29	score	score	NOUN
ct-10135	30	30	at	at	ADP
ct-10135	30	31	the	the	DET
ct-10135	30	32	time	time	NOUN
ct-10135	30	33	of	of	ADP
ct-10135	30	34	deslorelin	deslorelin	NOUN
ct-10135	30	35	treatment	treatment	NOUN
ct-10135	30	36	(	(	PUNCT
ct-10135	30	37	table	table	NOUN
ct-10135	30	38	)	)	PUNCT
ct-10135	30	39	.	.	PUNCT
ct-10135	31	1	the	the	DET
ct-10135	31	2	2009	2009	NUM
ct-10135	31	3	lyophilized	lyophilized	ADJ
ct-10135	31	4	deslorelin	deslorelin	NOUN
ct-10135	31	5	treated	treat	VERB
ct-10135	31	6	mares	mare	NOUN
ct-10135	31	7	had	have	VERB
ct-10135	31	8	smaller	small	ADJ
ct-10135	31	9	follicles	follicle	NOUN
ct-10135	31	10	(	(	PUNCT
ct-10135	31	11	p	p	X
ct-10135	31	12	<	<	X
ct-10135	31	13	0.05	0.05	NUM
ct-10135	31	14	)	)	PUNCT
ct-10135	31	15	at	at	ADP
ct-10135	31	16	the	the	DET
ct-10135	31	17	time	time	NOUN
ct-10135	31	18	of	of	ADP
ct-10135	31	19	treatment	treatment	NOUN
ct-10135	31	20	as	as	ADP
ct-10135	31	21	compared	compare	VERB
ct-10135	31	22	to	to	ADP
ct-10135	31	23	the	the	DET
ct-10135	31	24	mares	mare	NOUN
ct-10135	31	25	administered	administer	VERB
ct-10135	31	26	liquid	liquid	ADJ
ct-10135	31	27	deslorelin	deslorelin	NOUN
ct-10135	31	28	.	.	PUNCT
ct-10135	32	1	the	the	DET
ct-10135	32	2	2010	2010	NUM
ct-10135	32	3	lypholilized	lypholilize	VERB
ct-10135	32	4	deslorelin	deslorelin	NOUN
ct-10135	32	5	treated	treat	VERB
ct-10135	32	6	mares	mare	NOUN
ct-10135	32	7	had	have	VERB
ct-10135	32	8	less	less	ADJ
ct-10135	32	9	uterine	uterine	ADJ
ct-10135	32	10	edema	edema	NOUN
ct-10135	32	11	(	(	PUNCT
ct-10135	32	12	p	p	X
ct-10135	32	13	<	<	X
ct-10135	32	14	0.05	0.05	NUM
ct-10135	32	15	)	)	PUNCT
ct-10135	32	16	at	at	ADP
ct-10135	32	17	the	the	DET
ct-10135	32	18	time	time	NOUN
ct-10135	32	19	of	of	ADP
ct-10135	32	20	treatment	treatment	NOUN
ct-10135	32	21	as	as	SCONJ
ct-10135	32	22	compared	compare	VERB
ct-10135	32	23	to	to	ADP
ct-10135	32	24	the	the	DET
ct-10135	32	25	mares	mare	NOUN
ct-10135	32	26	administered	administer	VERB
ct-10135	32	27	liquid	liquid	ADJ
ct-10135	32	28	deslorelin	deslorelin	NOUN
ct-10135	32	29	.	.	PUNCT
ct-10135	33	1	there	there	PRON
ct-10135	33	2	was	be	VERB
ct-10135	33	3	no	no	DET
ct-10135	33	4	significant	significant	ADJ
ct-10135	33	5	difference	difference	NOUN
ct-10135	33	6	in	in	ADP
ct-10135	33	7	the	the	DET
ct-10135	33	8	interval	interval	NOUN
ct-10135	33	9	to	to	ADP
ct-10135	33	10	ovulation	ovulation	NOUN
ct-10135	33	11	between	between	ADP
ct-10135	33	12	mares	mare	NOUN
ct-10135	33	13	treated	treat	VERB
ct-10135	33	14	with	with	ADP
ct-10135	33	15	lyophilized	lyophilized	ADJ
ct-10135	33	16	deslorelin	deslorelin	NOUN
ct-10135	33	17	in	in	ADP
ct-10135	33	18	2009	2009	NUM
ct-10135	33	19	,	,	PUNCT
ct-10135	33	20	mares	mare	NOUN
ct-10135	33	21	treated	treat	VERB
ct-10135	33	22	with	with	ADP
ct-10135	33	23	the	the	DET
ct-10135	33	24	same	same	ADJ
ct-10135	33	25	lot	lot	NOUN
ct-10135	33	26	of	of	ADP
ct-10135	33	27	lyophilized	lyophilized	ADJ
ct-10135	33	28	deslorelin	deslorelin	NOUN
ct-10135	33	29	in	in	ADP
ct-10135	33	30	2010	2010	NUM
ct-10135	33	31	,	,	PUNCT
ct-10135	33	32	and	and	CCONJ
ct-10135	33	33	mares	mare	NOUN
ct-10135	33	34	treated	treat	VERB
ct-10135	33	35	with	with	ADP
ct-10135	33	36	deslorelin	deslorelin	NOUN
ct-10135	33	37	in	in	ADP
ct-10135	33	38	liquid	liquid	ADJ
ct-10135	33	39	suspension	suspension	NOUN
ct-10135	33	40	.	.	PUNCT
ct-10135	34	1	there	there	PRON
ct-10135	34	2	was	be	VERB
ct-10135	34	3	also	also	ADV
ct-10135	34	4	no	no	DET
ct-10135	34	5	difference	difference	NOUN
ct-10135	34	6	in	in	ADP
ct-10135	34	7	the	the	DET
ct-10135	34	8	percentage	percentage	NOUN
ct-10135	34	9	of	of	ADP
ct-10135	34	10	mares	mare	NOUN
ct-10135	34	11	ovulating	ovulate	VERB
ct-10135	34	12	within	within	ADP
ct-10135	34	13	48	48	NUM
ct-10135	34	14	hours	hour	NOUN
ct-10135	34	15	after	after	ADP
ct-10135	34	16	deslorelin	deslorelin	NOUN
ct-10135	34	17	administration	administration	NOUN
ct-10135	34	18	between	between	ADP
ct-10135	34	19	deslorelin	deslorelin	NOUN
ct-10135	34	20	treatment	treatment	NOUN
ct-10135	34	21	groups	group	NOUN
ct-10135	34	22	.	.	PUNCT
ct-10135	35	1	fifteen	fifteen	NUM
ct-10135	35	2	of	of	ADP
ct-10135	35	3	the	the	DET
ct-10135	35	4	24	24	NUM
ct-10135	35	5	mares	mare	NOUN
ct-10135	35	6	that	that	PRON
ct-10135	35	7	failed	fail	VERB
ct-10135	35	8	to	to	PART
ct-10135	35	9	ovulate	ovulate	VERB
ct-10135	35	10	within	within	ADP
ct-10135	35	11	48	48	NUM
ct-10135	35	12	hours	hour	NOUN
ct-10135	35	13	after	after	SCONJ
ct-10135	35	14	administration	administration	NOUN
ct-10135	35	15	of	of	ADP
ct-10135	35	16	deslorelin	deslorelin	NOUN
ct-10135	35	17	did	do	AUX
ct-10135	35	18	go	go	VERB
ct-10135	35	19	on	on	ADP
ct-10135	35	20	to	to	PART
ct-10135	35	21	ovulate	ovulate	VERB
ct-10135	35	22	within	within	ADP
ct-10135	35	23	the	the	DET
ct-10135	35	24	subsequent	subsequent	ADJ
ct-10135	35	25	24	24	NUM
ct-10135	35	26	hours	hour	NOUN
ct-10135	35	27	(	(	PUNCT
ct-10135	35	28	within	within	ADP
ct-10135	35	29	72	72	NUM
ct-10135	35	30	hours	hour	NOUN
ct-10135	35	31	after	after	ADP
ct-10135	35	32	deslorelin	deslorelin	NOUN
ct-10135	35	33	treatment	treatment	NOUN
ct-10135	35	34	)	)	PUNCT
ct-10135	35	35	.	.	PUNCT
ct-10135	36	1	these	these	DET
ct-10135	36	2	mares	mare	NOUN
ct-10135	36	3	had	have	VERB
ct-10135	36	4	significantly	significantly	ADV
ct-10135	36	5	(	(	PUNCT
ct-10135	36	6	p	p	X
ct-10135	36	7	<	<	X
ct-10135	36	8	0.05	0.05	NUM
ct-10135	36	9	)	)	PUNCT
ct-10135	36	10	smaller	small	ADJ
ct-10135	36	11	follicles	follicle	NOUN
ct-10135	36	12	(	(	PUNCT
ct-10135	36	13	37.7	37.7	NUM
ct-10135	36	14			PROPN
ct-10135	36	15	3.2	3.2	NUM
ct-10135	36	16	mm	mm	NOUN
ct-10135	36	17	)	)	PUNCT
ct-10135	36	18	at	at	ADP
ct-10135	36	19	the	the	DET
ct-10135	36	20	time	time	NOUN
ct-10135	36	21	of	of	ADP
ct-10135	36	22	deslorelin	deslorelin	NOUN
ct-10135	36	23	treatment	treatment	NOUN
ct-10135	36	24	than	than	ADP
ct-10135	36	25	mares	mare	NOUN
ct-10135	36	26	that	that	PRON
ct-10135	36	27	ovulated	ovulate	VERB
ct-10135	36	28	by	by	ADP
ct-10135	36	29	48	48	NUM
ct-10135	36	30	hours	hour	NOUN
ct-10135	36	31	(	(	PUNCT
ct-10135	36	32	40.9	40.9	NUM
ct-10135	36	33			PROPN
ct-10135	36	34	4.6	4.6	NUM
ct-10135	36	35	mm	mm	NOUN
ct-10135	36	36	)	)	PUNCT
ct-10135	36	37	.	.	PUNCT
ct-10135	37	1	there	there	PRON
ct-10135	37	2	was	be	VERB
ct-10135	37	3	no	no	DET
ct-10135	37	4	difference	difference	NOUN
ct-10135	37	5	(	(	PUNCT
ct-10135	37	6	p	p	X
ct-10135	37	7	>	>	X
ct-10135	37	8	0.05	0.05	NUM
ct-10135	37	9	)	)	PUNCT
ct-10135	37	10	in	in	ADP
ct-10135	37	11	uterine	uterine	ADJ
ct-10135	37	12	edema	edema	NOUN
ct-10135	37	13	or	or	CCONJ
ct-10135	37	14	month	month	NOUN
ct-10135	37	15	of	of	ADP
ct-10135	37	16	year	year	NOUN
ct-10135	37	17	between	between	ADP
ct-10135	37	18	mares	mare	NOUN
ct-10135	37	19	that	that	PRON
ct-10135	37	20	ovulated	ovulate	VERB
ct-10135	37	21	by	by	ADP
ct-10135	37	22	72	72	NUM
ct-10135	37	23	hours	hour	NOUN
ct-10135	37	24	versus	versus	ADP
ct-10135	37	25	mares	mare	NOUN
ct-10135	37	26	that	that	PRON
ct-10135	37	27	ovulated	ovulate	VERB
ct-10135	37	28	by	by	ADP
ct-10135	37	29	48	48	NUM
ct-10135	37	30	hours	hour	NOUN
ct-10135	37	31	post	post	ADJ
ct-10135	37	32	-	-	NOUN
ct-10135	37	33	treatment	treatment	NOUN
ct-10135	37	34	with	with	ADP
ct-10135	37	35	deslorelin	deslorelin	NOUN
ct-10135	37	36	.	.	PUNCT
ct-10135	38	1	combining	combine	VERB
ct-10135	38	2	all	all	DET
ct-10135	38	3	three	three	NUM
ct-10135	38	4	deslorelin	deslorelin	NOUN
ct-10135	38	5	treatment	treatment	NOUN
ct-10135	38	6	groups	group	NOUN
ct-10135	38	7	,	,	PUNCT
ct-10135	38	8	a	a	DET
ct-10135	38	9	total	total	NOUN
ct-10135	38	10	of	of	ADP
ct-10135	38	11	35	35	NUM
ct-10135	38	12	of	of	ADP
ct-10135	38	13	231	231	NUM
ct-10135	38	14	(	(	PUNCT
ct-10135	38	15	15.2	15.2	NUM
ct-10135	38	16	%	%	NOUN
ct-10135	38	17	)	)	PUNCT
ct-10135	38	18	treated	treat	VERB
ct-10135	38	19	mares	mare	NOUN
ct-10135	38	20	ovulated	ovulate	VERB
ct-10135	38	21	within	within	ADP
ct-10135	38	22	24	24	NUM
ct-10135	38	23	hours	hour	NOUN
ct-10135	38	24	while	while	SCONJ
ct-10135	38	25	the	the	DET
ct-10135	38	26	majority	majority	NOUN
ct-10135	38	27	of	of	ADP
ct-10135	38	28	treated	treat	VERB
ct-10135	38	29	mares	mare	NOUN
ct-10135	38	30	(	(	PUNCT
ct-10135	38	31	172	172	NUM
ct-10135	38	32	of	of	ADP
ct-10135	38	33	231	231	NUM
ct-10135	38	34	;	;	PUNCT
ct-10135	38	35	74.5	74.5	NUM
ct-10135	38	36	%	%	NOUN
ct-10135	38	37	)	)	PUNCT
ct-10135	38	38	ovulated	ovulate	VERB
ct-10135	38	39	between	between	ADP
ct-10135	38	40	24	24	NUM
ct-10135	38	41	and	and	CCONJ
ct-10135	38	42	48	48	NUM
ct-10135	38	43	hours	hour	NOUN
ct-10135	38	44	after	after	ADP
ct-10135	38	45	deslorelin	deslorelin	NOUN
ct-10135	38	46	administration	administration	NOUN
ct-10135	38	47	.	.	PUNCT
ct-10135	39	1	mares	mare	NOUN
ct-10135	39	2	that	that	PRON
ct-10135	39	3	ovulated	ovulate	VERB
ct-10135	39	4	within	within	ADP
ct-10135	39	5	24	24	NUM
ct-10135	39	6	hours	hour	NOUN
ct-10135	39	7	after	after	SCONJ
ct-10135	39	8	deslorelin	deslorelin	NOUN
ct-10135	39	9	administration	administration	NOUN
ct-10135	39	10	had	have	VERB
ct-10135	39	11	significantly	significantly	ADV
ct-10135	39	12	(	(	PUNCT
ct-10135	39	13	p<0.05	p<0.05	NOUN
ct-10135	39	14	)	)	PUNCT
ct-10135	39	15	larger	large	ADJ
ct-10135	39	16	follicles	follicle	NOUN
ct-10135	39	17	(	(	PUNCT
ct-10135	39	18	45.3	45.3	NUM
ct-10135	39	19			PROPN
ct-10135	39	20	4.6	4.6	NUM
ct-10135	39	21	mm	mm	NOUN
ct-10135	39	22	)	)	PUNCT
ct-10135	39	23	at	at	ADP
ct-10135	39	24	the	the	DET
ct-10135	39	25	time	time	NOUN
ct-10135	39	26	of	of	ADP
ct-10135	39	27	treatment	treatment	NOUN
ct-10135	39	28	as	as	SCONJ
ct-10135	39	29	compared	compare	VERB
ct-10135	39	30	to	to	ADP
ct-10135	39	31	mares	mare	NOUN
ct-10135	39	32	that	that	PRON
ct-10135	39	33	ovulated	ovulate	VERB
ct-10135	39	34	within	within	ADP
ct-10135	39	35	48	48	NUM
ct-10135	39	36	hours	hour	NOUN
ct-10135	39	37	(	(	PUNCT
ct-10135	39	38	40.9	40.9	NUM
ct-10135	39	39			PROPN
ct-10135	39	40	4.6	4.6	NUM
ct-10135	39	41	mm	mm	NOUN
ct-10135	39	42	)	)	PUNCT
ct-10135	39	43	.	.	PUNCT
ct-10135	40	1	there	there	PRON
ct-10135	40	2	was	be	VERB
ct-10135	40	3	no	no	DET
ct-10135	40	4	difference	difference	NOUN
ct-10135	40	5	in	in	ADP
ct-10135	40	6	edema	edema	NOUN
ct-10135	40	7	scores	score	NOUN
ct-10135	40	8	or	or	CCONJ
ct-10135	40	9	month	month	NOUN
ct-10135	40	10	of	of	ADP
ct-10135	40	11	year	year	NOUN
ct-10135	40	12	at	at	ADP
ct-10135	40	13	the	the	DET
ct-10135	40	14	time	time	NOUN
ct-10135	40	15	of	of	ADP
ct-10135	40	16	treatment	treatment	NOUN
ct-10135	40	17	between	between	ADP
ct-10135	40	18	mares	mare	NOUN
ct-10135	40	19	that	that	PRON
ct-10135	40	20	ovulated	ovulate	VERB
ct-10135	40	21	by	by	ADP
ct-10135	40	22	24	24	NUM
ct-10135	40	23	or	or	CCONJ
ct-10135	40	24	48	48	NUM
ct-10135	40	25	hours	hour	NOUN
ct-10135	40	26	after	after	ADP
ct-10135	40	27	administration	administration	NOUN
ct-10135	40	28	of	of	ADP
ct-10135	40	29	deslorelin	deslorelin	NOUN
ct-10135	40	30	(	(	PUNCT
ct-10135	40	31	data	datum	NOUN
ct-10135	40	32	not	not	PART
ct-10135	40	33	shown	show	VERB
ct-10135	40	34	)	)	PUNCT
ct-10135	40	35	.	.	PUNCT
ct-10135	41	1	when	when	SCONJ
ct-10135	41	2	the	the	DET
ct-10135	41	3	three	three	NUM
ct-10135	41	4	deslorelin	deslorelin	NOUN
ct-10135	41	5	treatment	treatment	NOUN
ct-10135	41	6	groups	group	NOUN
ct-10135	41	7	were	be	AUX
ct-10135	41	8	combined	combine	VERB
ct-10135	41	9	,	,	PUNCT
ct-10135	41	10	207	207	NUM
ct-10135	41	11	of	of	ADP
ct-10135	41	12	231	231	NUM
ct-10135	41	13	mares	mare	NOUN
ct-10135	41	14	(	(	PUNCT
ct-10135	41	15	89.6	89.6	NUM
ct-10135	41	16	%	%	NOUN
ct-10135	41	17	)	)	PUNCT
ct-10135	41	18	ovulated	ovulate	VERB
ct-10135	41	19	within	within	ADP
ct-10135	41	20	48	48	NUM
ct-10135	41	21	hours	hour	NOUN
ct-10135	41	22	of	of	ADP
ct-10135	41	23	gnrh	gnrh	NOUN
ct-10135	41	24	agonist	agonist	NOUN
ct-10135	41	25	administration	administration	NOUN
ct-10135	41	26	(	(	PUNCT
ct-10135	41	27	figure	figure	NOUN
ct-10135	41	28	)	)	PUNCT
ct-10135	41	29	.	.	PUNCT
ct-10135	42	1	of	of	ADP
ct-10135	42	2	the	the	DET
ct-10135	42	3	remaining	remain	VERB
ct-10135	42	4	24	24	NUM
ct-10135	42	5	mares	mare	NOUN
ct-10135	42	6	,	,	PUNCT
ct-10135	42	7	15	15	NUM
ct-10135	42	8	(	(	PUNCT
ct-10135	42	9	6.5	6.5	NUM
ct-10135	42	10	%	%	NOUN
ct-10135	42	11	)	)	PUNCT
ct-10135	42	12	ovulated	ovulate	VERB
ct-10135	42	13	3	3	NUM
ct-10135	42	14	days	day	NOUN
ct-10135	42	15	after	after	ADP
ct-10135	42	16	treatment	treatment	NOUN
ct-10135	42	17	,	,	PUNCT
ct-10135	42	18	5	5	NUM
ct-10135	42	19	(	(	PUNCT
ct-10135	42	20	2.2	2.2	NUM
ct-10135	42	21	%	%	NOUN
ct-10135	42	22	)	)	PUNCT
ct-10135	42	23	developed	develop	VERB
ct-10135	42	24	hemorrhagic	hemorrhagic	NOUN
ct-10135	42	25	follicles	follicle	NOUN
ct-10135	42	26	,	,	PUNCT
ct-10135	42	27	3	3	NUM
ct-10135	42	28	(	(	PUNCT
ct-10135	42	29	1.3	1.3	NUM
ct-10135	42	30	%	%	NOUN
ct-10135	42	31	)	)	PUNCT
ct-10135	42	32	ovulated	ovulate	VERB
ct-10135	42	33	after	after	SCONJ
ct-10135	42	34	hcg	hcg	PROPN
ct-10135	42	35	was	be	AUX
ct-10135	42	36	administered	administer	VERB
ct-10135	42	37	(	(	PUNCT
ct-10135	42	38	2	2	NUM
ct-10135	42	39	days	day	NOUN
ct-10135	42	40	after	after	ADP
ct-10135	42	41	deslorelin	deslorelin	NOUN
ct-10135	42	42	treatment	treatment	NOUN
ct-10135	42	43	)	)	PUNCT
ct-10135	42	44	,	,	PUNCT
ct-10135	42	45	and	and	CCONJ
ct-10135	42	46	the	the	DET
ct-10135	42	47	dominant	dominant	ADJ
ct-10135	42	48	follicle	follicle	NOUN
ct-10135	42	49	of	of	ADP
ct-10135	42	50	1	1	NUM
ct-10135	42	51	(	(	PUNCT
ct-10135	42	52	0.4	0.4	NUM
ct-10135	42	53	%	%	NOUN
ct-10135	42	54	)	)	PUNCT
ct-10135	42	55	mare	mare	NOUN
ct-10135	42	56	regressed	regress	VERB
ct-10135	42	57	.	.	PUNCT
ct-10135	43	1	100clinical	100clinical	ADJ
ct-10135	43	2	theriogenology	theriogenology	NOUN
ct-10135	43	3	•	•	NOUN
ct-10135	43	4	volume	volume	NOUN
ct-10135	43	5	3	3	NUM
ct-10135	43	6	number	number	NOUN
ct-10135	43	7	2	2	NUM
ct-10135	43	8	•	•	NOUN
ct-10135	43	9	june	june	PROPN
ct-10135	43	10	2011	2011	NUM
ct-10135	43	11	discussion	discussion	NOUN
ct-10135	43	12	deslorelin	deslorelin	NOUN
ct-10135	43	13	stimulates	stimulate	VERB
ct-10135	43	14	a	a	DET
ct-10135	43	15	prolonged	prolonged	ADJ
ct-10135	43	16	release	release	NOUN
ct-10135	43	17	of	of	ADP
ct-10135	43	18	luteinizing	luteinize	VERB
ct-10135	43	19	hormone	hormone	NOUN
ct-10135	43	20	(	(	PUNCT
ct-10135	43	21	lh	lh	PROPN
ct-10135	43	22	)	)	PUNCT
ct-10135	43	23	from	from	ADP
ct-10135	43	24	the	the	DET
ct-10135	43	25	anterior	anterior	ADJ
ct-10135	43	26	pituitary	pituitary	NOUN
ct-10135	43	27	that	that	PRON
ct-10135	43	28	induces	induce	VERB
ct-10135	43	29	ovulation	ovulation	NOUN
ct-10135	43	30	of	of	ADP
ct-10135	43	31	the	the	DET
ct-10135	43	32	dominant	dominant	ADJ
ct-10135	43	33	follicle	follicle	NOUN
ct-10135	43	34	in	in	ADP
ct-10135	43	35	mares	mare	NOUN
ct-10135	43	36	in	in	ADP
ct-10135	43	37	estrus.8	estrus.8	PROPN
ct-10135	43	38	mares	mare	NOUN
ct-10135	43	39	may	may	AUX
ct-10135	43	40	be	be	AUX
ct-10135	43	41	administered	administer	VERB
ct-10135	43	42	deslorelin	deslorelin	NOUN
ct-10135	43	43	when	when	SCONJ
ct-10135	43	44	a	a	DET
ct-10135	43	45	timed	time	VERB
ct-10135	43	46	ovulation	ovulation	NOUN
ct-10135	43	47	is	be	AUX
ct-10135	43	48	desired	desire	VERB
ct-10135	43	49	,	,	PUNCT
ct-10135	43	50	such	such	ADJ
ct-10135	43	51	as	as	ADP
ct-10135	43	52	when	when	SCONJ
ct-10135	43	53	stallion	stallion	NOUN
ct-10135	43	54	or	or	CCONJ
ct-10135	43	55	semen	semen	NOUN
ct-10135	43	56	availability	availability	NOUN
ct-10135	43	57	is	be	AUX
ct-10135	43	58	limited	limit	VERB
ct-10135	43	59	or	or	CCONJ
ct-10135	43	60	in	in	ADP
ct-10135	43	61	the	the	DET
ct-10135	43	62	use	use	NOUN
ct-10135	43	63	of	of	ADP
ct-10135	43	64	cooled	cool	VERB
ct-10135	43	65	-	-	PUNCT
ct-10135	43	66	transported	transport	VERB
ct-10135	43	67	semen	semen	NOUN
ct-10135	43	68	or	or	CCONJ
ct-10135	43	69	frozen	frozen	ADJ
ct-10135	43	70	semen	semen	NOUN
ct-10135	43	71	.	.	PUNCT
ct-10135	44	1	timing	timing	NOUN
ct-10135	44	2	of	of	ADP
ct-10135	44	3	deslorelin	deslorelin	NOUN
ct-10135	44	4	administration	administration	NOUN
ct-10135	44	5	during	during	ADP
ct-10135	44	6	the	the	DET
ct-10135	44	7	estrous	estrous	ADJ
ct-10135	44	8	cycle	cycle	NOUN
ct-10135	44	9	is	be	AUX
ct-10135	44	10	critical	critical	ADJ
ct-10135	44	11	for	for	ADP
ct-10135	44	12	successful	successful	ADJ
ct-10135	44	13	outcome	outcome	NOUN
ct-10135	44	14	.	.	PUNCT
ct-10135	45	1	in	in	ADP
ct-10135	45	2	light	light	ADJ
ct-10135	45	3	horse	horse	NOUN
ct-10135	45	4	breeds	breed	NOUN
ct-10135	45	5	,	,	PUNCT
ct-10135	45	6	it	it	PRON
ct-10135	45	7	is	be	AUX
ct-10135	45	8	recommended	recommend	VERB
ct-10135	45	9	that	that	SCONJ
ct-10135	45	10	deslorelin	deslorelin	NOUN
ct-10135	45	11	be	be	AUX
ct-10135	45	12	administered	administer	VERB
ct-10135	45	13	when	when	SCONJ
ct-10135	45	14	the	the	DET
ct-10135	45	15	dominant	dominant	ADJ
ct-10135	45	16	follicle	follicle	NOUN
ct-10135	45	17	first	first	ADV
ct-10135	45	18	develops	develop	VERB
ct-10135	45	19	to	to	ADP
ct-10135	45	20	a	a	DET
ct-10135	45	21	diameter	diameter	NOUN
ct-10135	45	22	of	of	ADP
ct-10135	45	23	35	35	NUM
ct-10135	45	24	mm	mm	NOUN
ct-10135	45	25	or	or	CCONJ
ct-10135	45	26	greater	great	ADJ
ct-10135	45	27	and	and	CCONJ
ct-10135	45	28	edema	edema	NOUN
ct-10135	45	29	is	be	AUX
ct-10135	45	30	present	present	ADJ
ct-10135	45	31	in	in	ADP
ct-10135	45	32	the	the	DET
ct-10135	45	33	endometrium.4	endometrium.4	NOUN
ct-10135	45	34	with	with	ADP
ct-10135	45	35	this	this	DET
ct-10135	45	36	treatment	treatment	NOUN
ct-10135	45	37	protocol	protocol	NOUN
ct-10135	45	38	,	,	PUNCT
ct-10135	45	39	a	a	DET
ct-10135	45	40	majority	majority	NOUN
ct-10135	45	41	of	of	ADP
ct-10135	45	42	mares	mare	NOUN
ct-10135	45	43	will	will	AUX
ct-10135	45	44	ovulate	ovulate	VERB
ct-10135	45	45	within	within	ADP
ct-10135	45	46	48	48	NUM
ct-10135	45	47	hours	hour	NOUN
ct-10135	45	48	after	after	ADP
ct-10135	45	49	treatment	treatment	NOUN
ct-10135	45	50	.	.	PUNCT
ct-10135	46	1	in	in	ADP
ct-10135	46	2	the	the	DET
ct-10135	46	3	current	current	ADJ
ct-10135	46	4	study	study	NOUN
ct-10135	46	5	,	,	PUNCT
ct-10135	46	6	the	the	DET
ct-10135	46	7	average	average	ADJ
ct-10135	46	8	interval	interval	NOUN
ct-10135	46	9	from	from	ADP
ct-10135	46	10	deslorelin	deslorelin	NOUN
ct-10135	46	11	treatment	treatment	NOUN
ct-10135	46	12	to	to	ADP
ct-10135	46	13	ovulation	ovulation	NOUN
ct-10135	46	14	,	,	PUNCT
ct-10135	46	15	based	base	VERB
ct-10135	46	16	on	on	ADP
ct-10135	46	17	ultrasound	ultrasound	NOUN
ct-10135	46	18	examinations	examination	NOUN
ct-10135	46	19	once	once	ADV
ct-10135	46	20	per	per	ADP
ct-10135	46	21	day	day	NOUN
ct-10135	46	22	,	,	PUNCT
ct-10135	46	23	was	be	AUX
ct-10135	46	24	1.9	1.9	NUM
ct-10135	46	25			PROPN
ct-10135	46	26	0.5	0.5	NUM
ct-10135	46	27	days	day	NOUN
ct-10135	46	28	.	.	PUNCT
ct-10135	47	1	consistency	consistency	NOUN
ct-10135	47	2	in	in	ADP
ct-10135	47	3	the	the	DET
ct-10135	47	4	interval	interval	NOUN
ct-10135	47	5	to	to	ADP
ct-10135	47	6	ovulation	ovulation	NOUN
ct-10135	47	7	is	be	AUX
ct-10135	47	8	an	an	DET
ct-10135	47	9	important	important	ADJ
ct-10135	47	10	attribute	attribute	NOUN
ct-10135	47	11	of	of	ADP
ct-10135	47	12	an	an	DET
ct-10135	47	13	ovulation	ovulation	NOUN
ct-10135	47	14	inducing	induce	VERB
ct-10135	47	15	agent	agent	NOUN
ct-10135	47	16	.	.	PUNCT
ct-10135	48	1	in	in	ADP
ct-10135	48	2	the	the	DET
ct-10135	48	3	case	case	NOUN
ct-10135	48	4	of	of	ADP
ct-10135	48	5	the	the	DET
ct-10135	48	6	lyophilized	lyophilized	ADJ
ct-10135	48	7	deslorelin	deslorelin	NOUN
ct-10135	48	8	,	,	PUNCT
ct-10135	48	9	90.0	90.0	NUM
ct-10135	48	10	%	%	NOUN
ct-10135	48	11	of	of	ADP
ct-10135	48	12	treated	treat	VERB
ct-10135	48	13	mares	mare	NOUN
ct-10135	48	14	ovulated	ovulate	VERB
ct-10135	48	15	within	within	ADP
ct-10135	48	16	48	48	NUM
ct-10135	48	17	hours	hour	NOUN
ct-10135	48	18	after	after	ADP
ct-10135	48	19	administration	administration	NOUN
ct-10135	48	20	.	.	PUNCT
ct-10135	49	1	mares	mare	NOUN
ct-10135	49	2	that	that	PRON
ct-10135	49	3	ovulated	ovulate	VERB
ct-10135	49	4	within	within	ADP
ct-10135	49	5	24	24	NUM
ct-10135	49	6	hours	hour	NOUN
ct-10135	49	7	after	after	SCONJ
ct-10135	49	8	treatment	treatment	NOUN
ct-10135	49	9	may	may	AUX
ct-10135	49	10	have	have	AUX
ct-10135	49	11	either	either	CCONJ
ct-10135	49	12	responded	respond	VERB
ct-10135	49	13	exceptionally	exceptionally	ADV
ct-10135	49	14	fast	fast	ADV
ct-10135	49	15	to	to	ADP
ct-10135	49	16	the	the	DET
ct-10135	49	17	gnrh	gnrh	NOUN
ct-10135	49	18	agonist	agonist	NOUN
ct-10135	49	19	or	or	CCONJ
ct-10135	49	20	the	the	DET
ct-10135	49	21	dominant	dominant	ADJ
ct-10135	49	22	follicle	follicle	NOUN
ct-10135	49	23	may	may	AUX
ct-10135	49	24	have	have	AUX
ct-10135	49	25	already	already	ADV
ct-10135	49	26	been	be	AUX
ct-10135	49	27	under	under	ADP
ct-10135	49	28	the	the	DET
ct-10135	49	29	influence	influence	NOUN
ct-10135	49	30	of	of	ADP
ct-10135	49	31	endogenous	endogenous	ADJ
ct-10135	49	32	lh	lh	PROPN
ct-10135	49	33	.	.	PUNCT
ct-10135	50	1	the	the	DET
ct-10135	50	2	percentage	percentage	NOUN
ct-10135	50	3	of	of	ADP
ct-10135	50	4	mares	mare	NOUN
ct-10135	50	5	that	that	PRON
ct-10135	50	6	ovulated	ovulate	VERB
ct-10135	50	7	within	within	ADP
ct-10135	50	8	24	24	NUM
ct-10135	50	9	hours	hour	NOUN
ct-10135	50	10	after	after	SCONJ
ct-10135	50	11	deslorelin	deslorelin	NOUN
ct-10135	50	12	treatment	treatment	NOUN
ct-10135	50	13	(	(	PUNCT
ct-10135	50	14	15.2	15.2	NUM
ct-10135	50	15	%	%	NOUN
ct-10135	50	16	)	)	PUNCT
ct-10135	50	17	was	be	AUX
ct-10135	50	18	similar	similar	ADJ
ct-10135	50	19	to	to	ADP
ct-10135	50	20	the	the	DET
ct-10135	50	21	percentage	percentage	NOUN
ct-10135	50	22	of	of	ADP
ct-10135	50	23	mares	mare	NOUN
ct-10135	50	24	that	that	PRON
ct-10135	50	25	ovulated	ovulate	VERB
ct-10135	50	26	within	within	ADP
ct-10135	50	27	24	24	NUM
ct-10135	50	28	hours	hour	NOUN
ct-10135	50	29	after	after	ADP
ct-10135	50	30	hcg	hcg	PROPN
ct-10135	50	31	administration	administration	PROPN
ct-10135	50	32	(	(	PUNCT
ct-10135	50	33	18.5	18.5	NUM
ct-10135	50	34	%	%	NOUN
ct-10135	50	35	)	)	PUNCT
ct-10135	50	36	in	in	ADP
ct-10135	50	37	a	a	DET
ct-10135	50	38	previous	previous	ADJ
ct-10135	50	39	retrospective	retrospective	NOUN
ct-10135	50	40	study.3	study.3	NOUN
ct-10135	50	41	the	the	DET
ct-10135	50	42	larger	large	ADJ
ct-10135	50	43	follicle	follicle	NOUN
ct-10135	50	44	diameter	diameter	NOUN
ct-10135	50	45	in	in	ADP
ct-10135	50	46	mares	mare	NOUN
ct-10135	50	47	that	that	PRON
ct-10135	50	48	ovulated	ovulate	VERB
ct-10135	50	49	within	within	ADP
ct-10135	50	50	24	24	NUM
ct-10135	50	51	hours	hour	NOUN
ct-10135	50	52	(	(	PUNCT
ct-10135	50	53	45.3	45.3	NUM
ct-10135	50	54			PROPN
ct-10135	50	55	4.6	4.6	NUM
ct-10135	50	56	mm	mm	NOUN
ct-10135	50	57	)	)	PUNCT
ct-10135	50	58	as	as	SCONJ
ct-10135	50	59	compared	compare	VERB
ct-10135	50	60	to	to	ADP
ct-10135	50	61	mares	mare	NOUN
ct-10135	50	62	that	that	PRON
ct-10135	50	63	ovulated	ovulate	VERB
ct-10135	50	64	between	between	ADP
ct-10135	50	65	24	24	NUM
ct-10135	50	66	and	and	CCONJ
ct-10135	50	67	48	48	NUM
ct-10135	50	68	hours	hour	NOUN
ct-10135	50	69	of	of	ADP
ct-10135	50	70	the	the	DET
ct-10135	50	71	deslorelin	deslorelin	NOUN
ct-10135	50	72	administration	administration	NOUN
ct-10135	50	73	(	(	PUNCT
ct-10135	50	74	40.9	40.9	NUM
ct-10135	50	75			PROPN
ct-10135	50	76	4.6	4.6	NUM
ct-10135	50	77	mm	mm	NOUN
ct-10135	50	78	)	)	PUNCT
ct-10135	50	79	suggests	suggest	VERB
ct-10135	50	80	that	that	SCONJ
ct-10135	50	81	mares	mare	NOUN
ct-10135	50	82	that	that	PRON
ct-10135	50	83	ovulated	ovulate	VERB
ct-10135	50	84	within	within	ADP
ct-10135	50	85	24	24	NUM
ct-10135	50	86	hours	hour	NOUN
ct-10135	50	87	of	of	ADP
ct-10135	50	88	treatment	treatment	NOUN
ct-10135	50	89	may	may	AUX
ct-10135	50	90	have	have	AUX
ct-10135	50	91	already	already	ADV
ct-10135	50	92	been	be	AUX
ct-10135	50	93	approaching	approach	VERB
ct-10135	50	94	ovulation	ovulation	NOUN
ct-10135	50	95	secondary	secondary	ADJ
ct-10135	50	96	to	to	ADP
ct-10135	50	97	a	a	DET
ct-10135	50	98	rise	rise	NOUN
ct-10135	50	99	in	in	ADP
ct-10135	50	100	endogenous	endogenous	ADJ
ct-10135	50	101	lh	lh	NOUN
ct-10135	50	102	.	.	PUNCT
ct-10135	51	1	unfortunately	unfortunately	ADV
ct-10135	51	2	,	,	PUNCT
ct-10135	51	3	endogenous	endogenous	ADJ
ct-10135	51	4	lh	lh	PROPN
ct-10135	51	5	concentrations	concentration	NOUN
ct-10135	51	6	were	be	AUX
ct-10135	51	7	not	not	PART
ct-10135	51	8	evaluated	evaluate	VERB
ct-10135	51	9	in	in	ADP
ct-10135	51	10	this	this	DET
ct-10135	51	11	study	study	NOUN
ct-10135	51	12	.	.	PUNCT
ct-10135	52	1	the	the	DET
ct-10135	52	2	obvious	obvious	ADJ
ct-10135	52	3	clinical	clinical	ADJ
ct-10135	52	4	implication	implication	NOUN
ct-10135	52	5	of	of	ADP
ct-10135	52	6	this	this	DET
ct-10135	52	7	observation	observation	NOUN
ct-10135	52	8	is	be	AUX
ct-10135	52	9	that	that	SCONJ
ct-10135	52	10	the	the	DET
ct-10135	52	11	administration	administration	NOUN
ct-10135	52	12	of	of	ADP
ct-10135	52	13	deslorelin	deslorelin	NOUN
ct-10135	52	14	does	do	AUX
ct-10135	52	15	not	not	PART
ct-10135	52	16	preclude	preclude	VERB
ct-10135	52	17	a	a	DET
ct-10135	52	18	mare	mare	NOUN
ct-10135	52	19	in	in	ADP
ct-10135	52	20	estrus	estrus	NOUN
ct-10135	52	21	from	from	ADP
ct-10135	52	22	ovulating	ovulate	VERB
ct-10135	52	23	within	within	ADP
ct-10135	52	24	24	24	NUM
ct-10135	52	25	hours	hour	NOUN
ct-10135	52	26	.	.	PUNCT
ct-10135	53	1	five	five	NUM
ct-10135	53	2	of	of	ADP
ct-10135	53	3	the	the	DET
ct-10135	53	4	231	231	NUM
ct-10135	53	5	mares	mare	NOUN
ct-10135	53	6	(	(	PUNCT
ct-10135	53	7	2.2	2.2	NUM
ct-10135	53	8	%	%	NOUN
ct-10135	53	9	)	)	PUNCT
ct-10135	53	10	treated	treat	VERB
ct-10135	53	11	with	with	ADP
ct-10135	53	12	deslorelin	deslorelin	NOUN
ct-10135	53	13	developed	develop	VERB
ct-10135	53	14	hemorrhagic	hemorrhagic	NOUN
ct-10135	53	15	anovulatory	anovulatory	NOUN
ct-10135	53	16	follicles	follicle	NOUN
ct-10135	53	17	.	.	PUNCT
ct-10135	54	1	this	this	PRON
ct-10135	54	2	is	be	AUX
ct-10135	54	3	lower	low	ADJ
ct-10135	54	4	than	than	ADP
ct-10135	54	5	the	the	DET
ct-10135	54	6	percentage	percentage	NOUN
ct-10135	54	7	of	of	ADP
ct-10135	54	8	anovulatory	anovulatory	NOUN
ct-10135	54	9	follicles	follicle	NOUN
ct-10135	54	10	reported	report	VERB
ct-10135	54	11	in	in	ADP
ct-10135	54	12	other	other	ADJ
ct-10135	54	13	studies9	studies9	PROPN
ct-10135	54	14	-	-	PUNCT
ct-10135	54	15	11	11	NUM
ct-10135	54	16	and	and	CCONJ
ct-10135	54	17	suggests	suggest	VERB
ct-10135	54	18	that	that	SCONJ
ct-10135	54	19	there	there	PRON
ct-10135	54	20	is	be	VERB
ct-10135	54	21	no	no	DET
ct-10135	54	22	causative	causative	ADJ
ct-10135	54	23	relationship	relationship	NOUN
ct-10135	54	24	between	between	ADP
ct-10135	54	25	deslorelin	deslorelin	NOUN
ct-10135	54	26	administration	administration	NOUN
ct-10135	54	27	and	and	CCONJ
ct-10135	54	28	formation	formation	NOUN
ct-10135	54	29	of	of	ADP
ct-10135	54	30	anovulatory	anovulatory	NOUN
ct-10135	54	31	follicles	follicle	NOUN
ct-10135	54	32	.	.	PUNCT
ct-10135	55	1	results	result	NOUN
ct-10135	55	2	of	of	ADP
ct-10135	55	3	this	this	DET
ct-10135	55	4	study	study	NOUN
ct-10135	55	5	indicate	indicate	VERB
ct-10135	55	6	that	that	SCONJ
ct-10135	55	7	lyophilized	lyophilized	ADJ
ct-10135	55	8	deslorelin	deslorelin	NOUN
ct-10135	55	9	,	,	PUNCT
ct-10135	55	10	reconstituted	reconstitute	VERB
ct-10135	55	11	in	in	ADP
ct-10135	55	12	sterile	sterile	ADJ
ct-10135	55	13	saline	saline	NOUN
ct-10135	55	14	,	,	PUNCT
ct-10135	55	15	is	be	AUX
ct-10135	55	16	equally	equally	ADV
ct-10135	55	17	as	as	ADV
ct-10135	55	18	effective	effective	ADJ
ct-10135	55	19	in	in	ADP
ct-10135	55	20	inducing	induce	VERB
ct-10135	55	21	a	a	DET
ct-10135	55	22	timed	time	VERB
ct-10135	55	23	ovulation	ovulation	NOUN
ct-10135	55	24	in	in	ADP
ct-10135	55	25	estrual	estrual	ADJ
ct-10135	55	26	mares	mare	NOUN
ct-10135	55	27	as	as	ADP
ct-10135	55	28	deslorelin	deslorelin	NOUN
ct-10135	55	29	in	in	ADP
ct-10135	55	30	a	a	DET
ct-10135	55	31	liquid	liquid	ADJ
ct-10135	55	32	suspension	suspension	NOUN
ct-10135	55	33	.	.	PUNCT
ct-10135	56	1	in	in	ADP
ct-10135	56	2	addition	addition	NOUN
ct-10135	56	3	,	,	PUNCT
ct-10135	56	4	storage	storage	NOUN
ct-10135	56	5	of	of	ADP
ct-10135	56	6	lyophilized	lyophilized	ADJ
ct-10135	56	7	deslorelin	deslorelin	NOUN
ct-10135	56	8	at	at	ADP
ct-10135	56	9	room	room	NOUN
ct-10135	56	10	temperature	temperature	NOUN
ct-10135	56	11	for	for	ADP
ct-10135	56	12	12	12	NUM
ct-10135	56	13	months	month	NOUN
ct-10135	56	14	did	do	AUX
ct-10135	56	15	not	not	PART
ct-10135	56	16	adversely	adversely	ADV
ct-10135	56	17	affect	affect	VERB
ct-10135	56	18	efficacy	efficacy	NOUN
ct-10135	56	19	at	at	ADP
ct-10135	56	20	inducing	induce	VERB
ct-10135	56	21	ovulation	ovulation	NOUN
ct-10135	56	22	.	.	PUNCT
ct-10135	57	1	this	this	DET
ct-10135	57	2	information	information	NOUN
ct-10135	57	3	is	be	AUX
ct-10135	57	4	important	important	ADJ
ct-10135	57	5	in	in	ADP
ct-10135	57	6	clinical	clinical	ADJ
ct-10135	57	7	practice	practice	NOUN
ct-10135	57	8	,	,	PUNCT
ct-10135	57	9	as	as	SCONJ
ct-10135	57	10	non	non	ADJ
ct-10135	57	11	-	-	ADJ
ct-10135	57	12	reconstituted	reconstituted	ADJ
ct-10135	57	13	vials	vial	NOUN
ct-10135	57	14	of	of	ADP
ct-10135	57	15	lyophilized	lyophilized	ADJ
ct-10135	57	16	deslorelin	deslorelin	NOUN
ct-10135	57	17	may	may	AUX
ct-10135	57	18	be	be	AUX
ct-10135	57	19	stored	store	VERB
ct-10135	57	20	until	until	ADP
ct-10135	57	21	the	the	DET
ct-10135	57	22	next	next	ADJ
ct-10135	57	23	breeding	breeding	NOUN
ct-10135	57	24	season	season	NOUN
ct-10135	57	25	without	without	ADP
ct-10135	57	26	a	a	DET
ct-10135	57	27	loss	loss	NOUN
ct-10135	57	28	of	of	ADP
ct-10135	57	29	efficacy	efficacy	NOUN
ct-10135	57	30	.	.	PUNCT
ct-10135	58	1	however	however	ADV
ct-10135	58	2	,	,	PUNCT
ct-10135	58	3	this	this	DET
ct-10135	58	4	study	study	NOUN
ct-10135	58	5	only	only	ADV
ct-10135	58	6	evaluated	evaluate	VERB
ct-10135	58	7	efficacy	efficacy	NOUN
ct-10135	58	8	at	at	ADP
ct-10135	58	9	inducing	induce	VERB
ct-10135	58	10	ovulation	ovulation	NOUN
ct-10135	58	11	after	after	ADP
ct-10135	58	12	prolonged	prolong	VERB
ct-10135	58	13	storage	storage	NOUN
ct-10135	58	14	and	and	CCONJ
ct-10135	58	15	did	do	AUX
ct-10135	58	16	not	not	PART
ct-10135	58	17	address	address	VERB
ct-10135	58	18	any	any	DET
ct-10135	58	19	potential	potential	ADJ
ct-10135	58	20	loss	loss	NOUN
ct-10135	58	21	of	of	ADP
ct-10135	58	22	biological	biological	ADJ
ct-10135	58	23	activity	activity	NOUN
ct-10135	58	24	or	or	CCONJ
ct-10135	58	25	potency	potency	NOUN
ct-10135	58	26	.	.	PUNCT
ct-10135	59	1	the	the	DET
ct-10135	59	2	dose	dose	NOUN
ct-10135	59	3	of	of	ADP
ct-10135	59	4	deslorelin	deslorelin	NOUN
ct-10135	59	5	used	use	VERB
ct-10135	59	6	in	in	ADP
ct-10135	59	7	the	the	DET
ct-10135	59	8	current	current	ADJ
ct-10135	59	9	study	study	NOUN
ct-10135	59	10	was	be	AUX
ct-10135	59	11	1.5	1.5	NUM
ct-10135	59	12	mg	mg	NOUN
ct-10135	59	13	administered	administer	VERB
ct-10135	59	14	as	as	ADP
ct-10135	59	15	an	an	DET
ct-10135	59	16	intramuscular	intramuscular	ADJ
ct-10135	59	17	injection	injection	NOUN
ct-10135	59	18	.	.	PUNCT
ct-10135	60	1	results	result	NOUN
ct-10135	60	2	of	of	ADP
ct-10135	60	3	a	a	DET
ct-10135	60	4	recent	recent	ADJ
ct-10135	60	5	study	study	NOUN
ct-10135	60	6	suggest	suggest	VERB
ct-10135	60	7	that	that	SCONJ
ct-10135	60	8	intramuscular	intramuscular	ADJ
ct-10135	60	9	doses	dose	NOUN
ct-10135	60	10	of	of	ADP
ct-10135	60	11	1.5	1.5	NUM
ct-10135	60	12	mg	mg	NOUN
ct-10135	60	13	,	,	PUNCT
ct-10135	60	14	1.0	1.0	NUM
ct-10135	60	15	mg	mg	NOUN
ct-10135	60	16	and	and	CCONJ
ct-10135	60	17	0.5	0.5	NUM
ct-10135	60	18	mg	mg	NOUN
ct-10135	60	19	are	be	AUX
ct-10135	60	20	equally	equally	ADV
ct-10135	60	21	effective	effective	ADJ
ct-10135	60	22	in	in	ADP
ct-10135	60	23	inducing	induce	VERB
ct-10135	60	24	ovulation	ovulation	NOUN
ct-10135	60	25	in	in	ADP
ct-10135	60	26	mares.8	mares.8	PROPN
ct-10135	60	27	in	in	ADP
ct-10135	60	28	summary	summary	NOUN
ct-10135	60	29	,	,	PUNCT
ct-10135	60	30	a	a	DET
ct-10135	60	31	dose	dose	NOUN
ct-10135	60	32	of	of	ADP
ct-10135	60	33	1.5	1.5	NUM
ct-10135	60	34	mg	mg	NOUN
ct-10135	60	35	of	of	ADP
ct-10135	60	36	lyophilized	lyophilized	ADJ
ct-10135	60	37	deslorelin	deslorelin	NOUN
ct-10135	60	38	was	be	AUX
ct-10135	60	39	effective	effective	ADJ
ct-10135	60	40	in	in	ADP
ct-10135	60	41	inducing	induce	VERB
ct-10135	60	42	ovulation	ovulation	NOUN
ct-10135	60	43	in	in	ADP
ct-10135	60	44	estrual	estrual	ADJ
ct-10135	60	45	mares	mare	NOUN
ct-10135	60	46	.	.	PUNCT
ct-10135	61	1	storage	storage	NOUN
ct-10135	61	2	of	of	ADP
ct-10135	61	3	lyophilized	lyophilized	ADJ
ct-10135	61	4	deslorelin	deslorelin	NOUN
ct-10135	61	5	at	at	ADP
ct-10135	61	6	room	room	NOUN
ct-10135	61	7	temperature	temperature	NOUN
ct-10135	61	8	for	for	ADP
ct-10135	61	9	12	12	NUM
ct-10135	61	10	months	month	NOUN
ct-10135	61	11	was	be	AUX
ct-10135	61	12	not	not	PART
ct-10135	61	13	associated	associate	VERB
ct-10135	61	14	with	with	ADP
ct-10135	61	15	a	a	DET
ct-10135	61	16	decrease	decrease	NOUN
ct-10135	61	17	in	in	ADP
ct-10135	61	18	efficacy	efficacy	NOUN
ct-10135	61	19	.	.	PUNCT
ct-10135	62	1	references	reference	NOUN
ct-10135	62	2	1	1	NUM
ct-10135	62	3	.	.	PUNCT
ct-10135	62	4	barbacini	barbacini	PROPN
ct-10135	62	5	s	s	PROPN
ct-10135	62	6	,	,	PUNCT
ct-10135	62	7	zavaglia	zavaglia	PROPN
ct-10135	62	8	g	g	NOUN
ct-10135	62	9	,	,	PUNCT
ct-10135	62	10	gulden	gulden	VERB
ct-10135	62	11	p	p	X
ct-10135	62	12	,	,	PUNCT
ct-10135	62	13	et	et	PROPN
ct-10135	62	14	al	al	PROPN
ct-10135	62	15	:	:	PUNCT
ct-10135	62	16	retrospective	retrospective	ADJ
ct-10135	62	17	study	study	NOUN
ct-10135	62	18	on	on	ADP
ct-10135	62	19	the	the	DET
ct-10135	62	20	efficacy	efficacy	NOUN
ct-10135	62	21	of	of	ADP
ct-10135	62	22	hcg	hcg	PROPN
ct-10135	62	23	in	in	ADP
ct-10135	62	24	an	an	DET
ct-10135	62	25	equine	equine	ADJ
ct-10135	62	26	artificial	artificial	ADJ
ct-10135	62	27	insemination	insemination	NOUN
ct-10135	62	28	programme	programme	NOUN
ct-10135	62	29	using	use	VERB
ct-10135	62	30	frozen	frozen	ADJ
ct-10135	62	31	semen	semen	NOUN
ct-10135	62	32	.	.	PUNCT
ct-10135	63	1	equine	equine	NOUN
ct-10135	63	2	vet	vet	NOUN
ct-10135	63	3	educ	educ	VERB
ct-10135	63	4	2000;12:312	2000;12:312	NUM
ct-10135	63	5	-	-	PUNCT
ct-10135	63	6	317	317	NUM
ct-10135	63	7	.	.	X
ct-10135	64	1	2	2	NUM
ct-10135	64	2	.	.	X
ct-10135	64	3	green	green	PROPN
ct-10135	64	4	jm	jm	PROPN
ct-10135	64	5	,	,	PUNCT
ct-10135	64	6	raz	raz	PROPN
ct-10135	64	7	t	t	PROPN
ct-10135	64	8	,	,	PUNCT
ct-10135	64	9	epp	epp	PROPN
ct-10135	64	10	t	t	PROPN
ct-10135	64	11	,	,	PUNCT
ct-10135	64	12	et	et	PROPN
ct-10135	64	13	al	al	PROPN
ct-10135	64	14	;	;	PUNCT
ct-10135	64	15	relationship	relationship	NOUN
ct-10135	64	16	between	between	ADP
ct-10135	64	17	utero	utero	ADJ
ct-10135	64	18	-	-	PUNCT
ct-10135	64	19	ovarian	ovarian	ADJ
ct-10135	64	20	parameters	parameter	NOUN
ct-10135	64	21	in	in	ADP
ct-10135	64	22	the	the	DET
ct-10135	64	23	ovulatory	ovulatory	ADJ
ct-10135	64	24	response	response	NOUN
ct-10135	64	25	to	to	ADP
ct-10135	64	26	human	human	ADJ
ct-10135	64	27	chorionic	chorionic	ADJ
ct-10135	64	28	gonadotropin	gonadotropin	NOUN
ct-10135	64	29	in	in	ADP
ct-10135	64	30	mares	mare	NOUN
ct-10135	64	31	.	.	PUNCT
ct-10135	65	1	proc	proc	PROPN
ct-10135	65	2	annu	annu	PROPN
ct-10135	65	3	conv	conv	PROPN
ct-10135	65	4	am	am	PROPN
ct-10135	65	5	assoc	assoc	PROPN
ct-10135	65	6	equine	equine	PROPN
ct-10135	65	7	pract	pract	PROPN
ct-10135	65	8	2007	2007	NUM
ct-10135	65	9	.	.	PUNCT
ct-10135	66	1	p.	p.	NOUN
ct-10135	66	2	563	563	NUM
ct-10135	66	3	-	-	SYM
ct-10135	66	4	567	567	NUM
ct-10135	66	5	.	.	NOUN
ct-10135	66	6	3	3	NUM
ct-10135	66	7	.	.	X
ct-10135	66	8	mccue	mccue	PROPN
ct-10135	66	9	pm	pm	PROPN
ct-10135	66	10	,	,	PUNCT
ct-10135	66	11	hudson	hudson	PROPN
ct-10135	66	12	jj	jj	PROPN
ct-10135	66	13	,	,	PUNCT
ct-10135	66	14	bruemmer	bruemmer	PROPN
ct-10135	66	15	j	j	PROPN
ct-10135	66	16	,	,	PUNCT
ct-10135	66	17	et	et	PROPN
ct-10135	66	18	al	al	PROPN
ct-10135	66	19	:	:	PUNCT
ct-10135	66	20	efficacy	efficacy	NOUN
ct-10135	66	21	of	of	ADP
ct-10135	66	22	hcg	hcg	PROPN
ct-10135	66	23	at	at	ADP
ct-10135	66	24	inducing	induce	VERB
ct-10135	66	25	ovulation	ovulation	NOUN
ct-10135	66	26	:	:	PUNCT
ct-10135	66	27	a	a	DET
ct-10135	66	28	new	new	ADJ
ct-10135	66	29	look	look	NOUN
ct-10135	66	30	at	at	ADP
ct-10135	66	31	an	an	DET
ct-10135	66	32	old	old	ADJ
ct-10135	66	33	issue	issue	NOUN
ct-10135	66	34	.	.	PUNCT
ct-10135	67	1	proc	proc	PROPN
ct-10135	67	2	annu	annu	PROPN
ct-10135	67	3	conv	conv	PROPN
ct-10135	67	4	am	am	PROPN
ct-10135	67	5	assoc	assoc	PROPN
ct-10135	67	6	equine	equine	PROPN
ct-10135	67	7	pract	pract	PROPN
ct-10135	67	8	2004	2004	NUM
ct-10135	67	9	.	.	PUNCT
ct-10135	68	1	p.	p.	NOUN
ct-10135	68	2	510	510	NUM
ct-10135	68	3	-	-	SYM
ct-10135	68	4	513	513	NUM
ct-10135	68	5	.	.	PUNCT
ct-10135	68	6	4	4	X
ct-10135	68	7	.	.	X
ct-10135	69	1	mccue	mccue	PROPN
ct-10135	69	2	p	p	PROPN
ct-10135	69	3	,	,	PUNCT
ct-10135	69	4	magee	magee	PROPN
ct-10135	69	5	c	c	PROPN
ct-10135	69	6	,	,	PUNCT
ct-10135	69	7	gee	gee	NOUN
ct-10135	69	8	e	e	NOUN
ct-10135	69	9	:	:	PUNCT
ct-10135	69	10	comparison	comparison	NOUN
ct-10135	69	11	of	of	ADP
ct-10135	69	12	compounded	compound	VERB
ct-10135	69	13	deslorelin	deslorelin	NOUN
ct-10135	69	14	and	and	CCONJ
ct-10135	69	15	hcg	hcg	PROPN
ct-10135	69	16	for	for	ADP
ct-10135	69	17	induction	induction	NOUN
ct-10135	69	18	of	of	ADP
ct-10135	69	19	ovulation	ovulation	NOUN
ct-10135	69	20	in	in	ADP
ct-10135	69	21	mares	mare	NOUN
ct-10135	69	22	.	.	PUNCT
ct-10135	70	1	j	j	PROPN
ct-10135	70	2	equine	equine	PROPN
ct-10135	70	3	vet	vet	NOUN
ct-10135	70	4	sci	sci	PROPN
ct-10135	70	5	2007;27:58	2007;27:58	PROPN
ct-10135	70	6	-	-	PUNCT
ct-10135	70	7	61	61	NUM
ct-10135	70	8	.	.	PUNCT
ct-10135	71	1	101	101	NUM
ct-10135	71	2	clinical	clinical	ADJ
ct-10135	71	3	theriogenology	theriogenology	NOUN
ct-10135	71	4	•	•	NOUN
ct-10135	71	5	volume	volume	NOUN
ct-10135	71	6	3	3	NUM
ct-10135	71	7	number	number	NOUN
ct-10135	71	8	2	2	NUM
ct-10135	71	9	•	•	NOUN
ct-10135	71	10	june	june	PROPN
ct-10135	71	11	2011	2011	NUM
ct-10135	71	12	5	5	NUM
ct-10135	71	13	.	.	PUNCT
ct-10135	71	14	mckinnon	mckinnon	PROPN
ct-10135	71	15	ao	ao	PROPN
ct-10135	71	16	,	,	PUNCT
ct-10135	71	17	perriam	perriam	PROPN
ct-10135	71	18	wj	wj	PROPN
ct-10135	71	19	,	,	PUNCT
ct-10135	71	20	lescun	lescun	ADJ
ct-10135	71	21	tb	tb	NOUN
ct-10135	71	22	,	,	PUNCT
ct-10135	71	23	et	et	PROPN
ct-10135	71	24	al	al	PROPN
ct-10135	71	25	:	:	PUNCT
ct-10135	71	26	effect	effect	NOUN
ct-10135	71	27	of	of	ADP
ct-10135	71	28	a	a	DET
ct-10135	71	29	gnrh	gnrh	NOUN
ct-10135	71	30	analogue	analogue	NOUN
ct-10135	71	31	(	(	PUNCT
ct-10135	71	32	ovuplant	ovuplant	NOUN
ct-10135	71	33	)	)	PUNCT
ct-10135	71	34	,	,	PUNCT
ct-10135	71	35	hcg	hcg	PROPN
ct-10135	71	36	and	and	CCONJ
ct-10135	71	37	dexamethasone	dexamethasone	NOUN
ct-10135	71	38	on	on	ADP
ct-10135	71	39	time	time	NOUN
ct-10135	71	40	to	to	ADP
ct-10135	71	41	ovulation	ovulation	NOUN
ct-10135	71	42	in	in	ADP
ct-10135	71	43	cycling	cycling	NOUN
ct-10135	71	44	mares	mare	NOUN
ct-10135	71	45	.	.	PUNCT
ct-10135	72	1	world	world	NOUN
ct-10135	72	2	equine	equine	PROPN
ct-10135	72	3	vet	vet	NOUN
ct-10135	72	4	rev	rev	VERB
ct-10135	72	5	1997;2:16	1997;2:16	PROPN
ct-10135	72	6	-	-	PUNCT
ct-10135	72	7	18	18	NUM
ct-10135	72	8	.	.	NOUN
ct-10135	73	1	6	6	NUM
ct-10135	73	2	.	.	X
ct-10135	73	3	mumford	mumford	PROPN
ct-10135	73	4	el	el	PROPN
ct-10135	73	5	,	,	PUNCT
ct-10135	73	6	squires	squires	PROPN
ct-10135	73	7	el	el	PROPN
ct-10135	73	8	,	,	PUNCT
ct-10135	73	9	jochle	jochle	PROPN
ct-10135	73	10	e	e	NOUN
ct-10135	73	11	,	,	PUNCT
ct-10135	73	12	et	et	PROPN
ct-10135	73	13	al	al	PROPN
ct-10135	73	14	:	:	PUNCT
ct-10135	73	15	use	use	NOUN
ct-10135	73	16	of	of	ADP
ct-10135	73	17	deslorelin	deslorelin	ADJ
ct-10135	73	18	short	short	ADJ
ct-10135	73	19	-	-	PUNCT
ct-10135	73	20	term	term	NOUN
ct-10135	73	21	implants	implant	NOUN
ct-10135	73	22	to	to	PART
ct-10135	73	23	induce	induce	VERB
ct-10135	73	24	ovulation	ovulation	NOUN
ct-10135	73	25	in	in	ADP
ct-10135	73	26	cycling	cycle	VERB
ct-10135	73	27	mares	mare	NOUN
ct-10135	73	28	during	during	ADP
ct-10135	73	29	3	3	NUM
ct-10135	73	30	consecutive	consecutive	ADJ
ct-10135	73	31	estrous	estrous	ADJ
ct-10135	73	32	cycles	cycle	NOUN
ct-10135	73	33	.	.	PUNCT
ct-10135	74	1	anim	anim	NOUN
ct-10135	74	2	reprod	reprod	PROPN
ct-10135	74	3	sci	sci	PROPN
ct-10135	74	4	1995;39:129	1995;39:129	PROPN
ct-10135	74	5	-	-	PUNCT
ct-10135	74	6	140	140	NUM
ct-10135	74	7	.	.	PUNCT
ct-10135	75	1	7	7	X
ct-10135	75	2	.	.	X
ct-10135	75	3	ferris	ferris	PROPN
ct-10135	75	4	ra	ra	PROPN
ct-10135	75	5	,	,	PUNCT
ct-10135	75	6	mccue	mccue	PROPN
ct-10135	75	7	pm	pm	PROPN
ct-10135	75	8	:	:	PUNCT
ct-10135	75	9	the	the	DET
ct-10135	75	10	effects	effect	NOUN
ct-10135	75	11	of	of	ADP
ct-10135	75	12	dexamethasone	dexamethasone	NOUN
ct-10135	75	13	and	and	CCONJ
ct-10135	75	14	prednisolone	prednisolone	PROPN
ct-10135	75	15	on	on	ADP
ct-10135	75	16	pituitary	pituitary	ADJ
ct-10135	75	17	and	and	CCONJ
ct-10135	75	18	ovarian	ovarian	ADJ
ct-10135	75	19	function	function	NOUN
ct-10135	75	20	in	in	ADP
ct-10135	75	21	the	the	DET
ct-10135	75	22	mare	mare	NOUN
ct-10135	75	23	.	.	PUNCT
ct-10135	76	1	equine	equine	PROPN
ct-10135	76	2	vet	vet	PROPN
ct-10135	76	3	j	j	PROPN
ct-10135	76	4	2010;42:438	2010;42:438	NOUN
ct-10135	76	5	-	-	PUNCT
ct-10135	76	6	443	443	NUM
ct-10135	76	7	.	.	NOUN
ct-10135	76	8	8	8	NUM
ct-10135	76	9	.	.	X
ct-10135	77	1	lindholm	lindholm	PROPN
ct-10135	77	2	arg	arg	PROPN
ct-10135	77	3	,	,	PUNCT
ct-10135	77	4	bloemen	bloemen	PROPN
ct-10135	77	5	ehg	ehg	PROPN
ct-10135	77	6	,	,	PUNCT
ct-10135	77	7	brooks	brooks	PROPN
ct-10135	77	8	rm	rm	PROPN
ct-10135	77	9	,	,	PUNCT
ct-10135	77	10	et	et	PROPN
ct-10135	77	11	al	al	PROPN
ct-10135	77	12	:	:	PUNCT
ct-10135	77	13	comparison	comparison	NOUN
ct-10135	77	14	of	of	ADP
ct-10135	77	15	deslorelin	deslorelin	NOUN
ct-10135	77	16	and	and	CCONJ
ct-10135	77	17	buserelin	buserelin	NOUN
ct-10135	77	18	in	in	ADP
ct-10135	77	19	mares	mare	NOUN
ct-10135	77	20	:	:	PUNCT
ct-10135	77	21	lh	lh	PROPN
ct-10135	77	22	response	response	NOUN
ct-10135	77	23	and	and	CCONJ
ct-10135	77	24	induction	induction	NOUN
ct-10135	77	25	of	of	ADP
ct-10135	77	26	ovulation	ovulation	NOUN
ct-10135	77	27	.	.	PUNCT
ct-10135	78	1	anim	anim	PROPN
ct-10135	78	2	reprod	reprod	PROPN
ct-10135	78	3	sci	sci	PROPN
ct-10135	78	4	2010;121:68	2010;121:68	NUM
ct-10135	78	5	-	-	SYM
ct-10135	78	6	70	70	NUM
ct-10135	78	7	.	.	PUNCT
ct-10135	78	8	9	9	NUM
ct-10135	78	9	.	.	X
ct-10135	78	10	mccue	mccue	PROPN
ct-10135	78	11	pm	pm	PROPN
ct-10135	78	12	,	,	PUNCT
ct-10135	78	13	squires	squires	PROPN
ct-10135	78	14	el	el	PROPN
ct-10135	78	15	:	:	PUNCT
ct-10135	78	16	persistent	persistent	ADJ
ct-10135	78	17	anovulatory	anovulatory	NOUN
ct-10135	78	18	follicles	follicle	NOUN
ct-10135	78	19	.	.	PUNCT
ct-10135	79	1	theriogenology	theriogenology	NOUN
ct-10135	79	2	2002;58:541	2002;58:541	NUM
ct-10135	79	3	-	-	SYM
ct-10135	79	4	543	543	NUM
ct-10135	79	5	.	.	PUNCT
ct-10135	79	6	10	10	NUM
ct-10135	79	7	.	.	PUNCT
ct-10135	80	1	lefranc	lefranc	PROPN
ct-10135	80	2	ac	ac	PROPN
ct-10135	80	3	,	,	PUNCT
ct-10135	80	4	allen	allen	PROPN
ct-10135	80	5	wr	wr	PROPN
ct-10135	80	6	:	:	PUNCT
ct-10135	80	7	incidence	incidence	NOUN
ct-10135	80	8	and	and	CCONJ
ct-10135	80	9	morphology	morphology	NOUN
ct-10135	80	10	of	of	ADP
ct-10135	80	11	anovulatory	anovulatory	ADJ
ct-10135	80	12	haemorrhagic	haemorrhagic	ADJ
ct-10135	80	13	follicles	follicle	NOUN
ct-10135	80	14	in	in	ADP
ct-10135	80	15	the	the	DET
ct-10135	80	16	mare	mare	NOUN
ct-10135	80	17	.	.	PUNCT
ct-10135	81	1	pferdeheilkunde	pferdeheilkunde	PROPN
ct-10135	81	2	2003;19:611	2003;19:611	ADV
ct-10135	81	3	-	-	PUNCT
ct-10135	81	4	612	612	NUM
ct-10135	81	5	.	.	PUNCT
ct-10135	82	1	11	11	NUM
ct-10135	82	2	.	.	PUNCT
ct-10135	83	1	gastal	gastal	PROPN
ct-10135	83	2	el	el	PROPN
ct-10135	83	3	,	,	PUNCT
ct-10135	83	4	gastal	gastal	PROPN
ct-10135	83	5	mo	mo	PROPN
ct-10135	83	6	,	,	PUNCT
ct-10135	83	7	ginther	ginther	NOUN
ct-10135	83	8	oj	oj	PROPN
ct-10135	83	9	:	:	PUNCT
ct-10135	83	10	the	the	DET
ct-10135	83	11	suitability	suitability	NOUN
ct-10135	83	12	of	of	ADP
ct-10135	83	13	echotexture	echotexture	ADJ
ct-10135	83	14	characteristics	characteristic	NOUN
ct-10135	83	15	of	of	ADP
ct-10135	83	16	the	the	DET
ct-10135	83	17	follicular	follicular	ADJ
ct-10135	83	18	wall	wall	NOUN
ct-10135	83	19	for	for	ADP
ct-10135	83	20	identifying	identify	VERB
ct-10135	83	21	the	the	DET
ct-10135	83	22	optimal	optimal	ADJ
ct-10135	83	23	breeding	breeding	NOUN
ct-10135	83	24	day	day	NOUN
ct-10135	83	25	in	in	ADP
ct-10135	83	26	mares	mare	NOUN
ct-10135	83	27	.	.	PUNCT
ct-10135	84	1	theriogenology	theriogenology	NOUN
ct-10135	84	2	1998;50:1025	1998;50:1025	NUM
ct-10135	84	3	-	-	SYM
ct-10135	84	4	1038	1038	NUM
ct-10135	84	5	.	.	PUNCT
ct-10135	85	1	102clinical	102clinical	ADJ
ct-10135	85	2	theriogenology	theriogenology	NOUN
ct-10135	85	3	•	•	NOUN
ct-10135	85	4	volume	volume	NOUN
ct-10135	85	5	3	3	NUM
ct-10135	85	6	number	number	NOUN
ct-10135	85	7	2	2	NUM
ct-10135	85	8	•	•	NOUN
ct-10135	85	9	june	june	PROPN
ct-10135	85	10	2011	2011	NUM
ct-10135	85	11	table	table	NOUN
ct-10135	85	12	.	.	PUNCT
ct-10135	86	1	follicle	follicle	NOUN
ct-10135	86	2	diameter	diameter	NOUN
ct-10135	86	3	and	and	CCONJ
ct-10135	86	4	edema	edema	NOUN
ct-10135	86	5	score	score	NOUN
ct-10135	86	6	at	at	ADP
ct-10135	86	7	time	time	NOUN
ct-10135	86	8	of	of	ADP
ct-10135	86	9	treatment	treatment	NOUN
ct-10135	86	10	,	,	PUNCT
ct-10135	86	11	interval	interval	NOUN
ct-10135	86	12	to	to	ADP
ct-10135	86	13	ovulation	ovulation	NOUN
ct-10135	86	14	after	after	ADP
ct-10135	86	15	treatment	treatment	NOUN
ct-10135	86	16	,	,	PUNCT
ct-10135	86	17	and	and	CCONJ
ct-10135	86	18	percentage	percentage	NOUN
ct-10135	86	19	of	of	ADP
ct-10135	86	20	mares	mare	NOUN
ct-10135	86	21	ovulating	ovulate	VERB
ct-10135	86	22	within	within	ADP
ct-10135	86	23	48	48	NUM
ct-10135	86	24	hours	hour	NOUN
ct-10135	86	25	of	of	ADP
ct-10135	86	26	deslorelin	deslorelin	NOUN
ct-10135	86	27	treatment	treatment	NOUN
ct-10135	86	28	.	.	PUNCT
ct-10135	87	1	group	group	NOUN
ct-10135	87	2	(	(	PUNCT
ct-10135	87	3	n	n	CCONJ
ct-10135	87	4	)	)	PUNCT
ct-10135	87	5	follicle	follicle	NOUN
ct-10135	87	6	size	size	NOUN
ct-10135	87	7	(	(	PUNCT
ct-10135	87	8	mm	mm	NOUN
ct-10135	87	9	)	)	PUNCT
ct-10135	87	10	edema	edema	NOUN
ct-10135	87	11	score	score	NOUN
ct-10135	87	12	interval	interval	NOUN
ct-10135	87	13	to	to	ADP
ct-10135	87	14	ovulation	ovulation	NOUN
ct-10135	87	15	(	(	PUNCT
ct-10135	87	16	days	day	NOUN
ct-10135	87	17	)	)	PUNCT
ct-10135	87	18	%	%	NOUN
ct-10135	87	19	of	of	ADP
ct-10135	87	20	mares	mare	NOUN
ct-10135	87	21	ovulating	ovulate	VERB
ct-10135	87	22	within	within	ADP
ct-10135	87	23	48	48	NUM
ct-10135	87	24	hours	hour	NOUN
ct-10135	87	25	lyophilized	lyophilize	VERB
ct-10135	87	26	deslorelin	deslorelin	NOUN
ct-10135	87	27	(	(	PUNCT
ct-10135	87	28	2009	2009	NUM
ct-10135	87	29	)	)	PUNCT
ct-10135	87	30	66	66	NUM
ct-10135	87	31	40.9	40.9	NUM
ct-10135	87	32	±	±	NUM
ct-10135	87	33	4.4	4.4	NUM
ct-10135	87	34	*	*	SYM
ct-10135	87	35	1.6	1.6	NUM
ct-10135	87	36	±	±	NUM
ct-10135	87	37	0.7	0.7	NUM
ct-10135	87	38	1.9	1.9	NUM
ct-10135	87	39	±	±	NUM
ct-10135	87	40	0.5	0.5	NUM
ct-10135	87	41	58/66	58/66	NUM
ct-10135	87	42	(	(	PUNCT
ct-10135	87	43	87.9	87.9	NUM
ct-10135	87	44	%	%	NOUN
ct-10135	87	45	)	)	PUNCT
ct-10135	87	46	lyophilized	lyophilize	VERB
ct-10135	87	47	deslorelin	deslorelin	NOUN
ct-10135	87	48	(	(	PUNCT
ct-10135	87	49	2010	2010	NUM
ct-10135	87	50	)	)	PUNCT
ct-10135	87	51	135	135	NUM
ct-10135	87	52	41.0	41.0	NUM
ct-10135	87	53	±	±	NUM
ct-10135	87	54	5.0	5.0	NUM
ct-10135	87	55	1.4	1.4	NUM
ct-10135	87	56	±	±	NUM
ct-10135	87	57	0.6	0.6	NUM
ct-10135	87	58	*	*	SYM
ct-10135	87	59	1.9	1.9	NUM
ct-10135	87	60	±0.5	±0.5	PROPN
ct-10135	87	61	123/135	123/135	NUM
ct-10135	87	62	(	(	PUNCT
ct-10135	87	63	91.1	91.1	NUM
ct-10135	87	64	%	%	NOUN
ct-10135	87	65	)	)	PUNCT
ct-10135	87	66	liquid	liquid	ADJ
ct-10135	87	67	suspension	suspension	NOUN
ct-10135	87	68	deslorelin	deslorelin	NOUN
ct-10135	87	69	(	(	PUNCT
ct-10135	87	70	2010	2010	NUM
ct-10135	87	71	)	)	PUNCT
ct-10135	87	72	30	30	NUM
ct-10135	87	73	43.5	43.5	NUM
ct-10135	87	74	±	±	NUM
ct-10135	87	75	4.9	4.9	NUM
ct-10135	87	76	*	*	SYM
ct-10135	87	77	1.7	1.7	NUM
ct-10135	87	78	±	±	NUM
ct-10135	87	79	0.6	0.6	NUM
ct-10135	87	80	*	*	PUNCT
ct-10135	87	81	1.9	1.9	NUM
ct-10135	87	82	±	±	NUM
ct-10135	87	83	0.4	0.4	NUM
ct-10135	87	84	28/32	28/32	NUM
ct-10135	87	85	(	(	PUNCT
ct-10135	87	86	87.5	87.5	NUM
ct-10135	87	87	%	%	NOUN
ct-10135	87	88	)	)	PUNCT
ct-10135	87	89	*	*	PUNCT
ct-10135	87	90	within	within	ADP
ct-10135	87	91	columns	column	NOUN
ct-10135	87	92	indicates	indicate	VERB
ct-10135	87	93	a	a	DET
ct-10135	87	94	significant	significant	ADJ
ct-10135	87	95	difference	difference	NOUN
ct-10135	87	96	of	of	ADP
ct-10135	87	97	p	p	NOUN
ct-10135	87	98	<	<	NOUN
ct-10135	87	99	0.05	0.05	NUM
ct-10135	87	100	,	,	PUNCT
ct-10135	87	101	*	*	PUNCT
ct-10135	87	102	*	*	PUNCT
ct-10135	87	103	indicates	indicate	VERB
ct-10135	87	104	a	a	DET
ct-10135	87	105	significant	significant	ADJ
ct-10135	87	106	difference	difference	NOUN
ct-10135	87	107	of	of	ADP
ct-10135	87	108	p	p	NOUN
ct-10135	87	109	<	<	NOUN
ct-10135	87	110	0.01	0.01	NUM
ct-10135	87	111	)	)	PUNCT
ct-10135	87	112	figure	figure	NOUN
ct-10135	87	113	.	.	PUNCT
ct-10135	88	1	interval	interval	NOUN
ct-10135	88	2	from	from	ADP
ct-10135	88	3	treatment	treatment	NOUN
ct-10135	88	4	to	to	ADP
ct-10135	88	5	ovulation	ovulation	NOUN
ct-10135	88	6	for	for	ADP
ct-10135	88	7	mares	mare	NOUN
ct-10135	88	8	administered	administer	VERB
ct-10135	88	9	deslorelin	deslorelin	NOUN
ct-10135	88	10	acetate	acetate	NOUN
ct-10135	88	11	(	(	PUNCT
ct-10135	88	12	all	all	DET
ct-10135	88	13	treatment	treatment	NOUN
ct-10135	88	14	groups	group	NOUN
ct-10135	88	15	combined	combine	VERB
ct-10135	88	16	)	)	PUNCT
ct-10135	88	17	.	.	PUNCT
ct-10135	89	1	225	225	NUM
ct-10135	89	2	of	of	ADP
ct-10135	89	3	the	the	DET
ct-10135	89	4	231	231	NUM
ct-10135	89	5	mares	mare	NOUN
ct-10135	89	6	are	be	AUX
ct-10135	89	7	shown	show	VERB
ct-10135	89	8	in	in	ADP
ct-10135	89	9	the	the	DET
ct-10135	89	10	figure	figure	NOUN
ct-10135	89	11	,	,	PUNCT
ct-10135	89	12	5	5	NUM
ct-10135	89	13	mares	mare	NOUN
ct-10135	89	14	did	do	AUX
ct-10135	89	15	not	not	PART
ct-10135	89	16	ovulate	ovulate	VERB
ct-10135	89	17	due	due	ADJ
ct-10135	89	18	to	to	ADP
ct-10135	89	19	a	a	DET
ct-10135	89	20	hemorrhagic	hemorrhagic	ADJ
ct-10135	89	21	follicle	follicle	NOUN
ct-10135	89	22	,	,	PUNCT
ct-10135	89	23	and	and	CCONJ
ct-10135	89	24	the	the	DET
ct-10135	89	25	dominant	dominant	ADJ
ct-10135	89	26	follicle	follicle	NOUN
ct-10135	89	27	regressed	regress	VERB
ct-10135	89	28	in	in	ADP
ct-10135	89	29	1	1	NUM
ct-10135	89	30	mare	mare	NOUN
ct-10135	89	31	.	.	PUNCT
ct-10135	90	1	103	103	NUM
ct-10135	90	2	clinical	clinical	ADJ
ct-10135	90	3	theriogenology	theriogenology	NOUN
ct-10135	90	4	•	•	NOUN
ct-10135	90	5	volume	volume	NOUN
ct-10135	90	6	3	3	NUM
ct-10135	90	7	number	number	NOUN
ct-10135	90	8	2	2	NUM
ct-10135	90	9	•	•	NOUN
ct-10135	90	10	june	june	PROPN
ct-10135	90	11	2011	2011	NUM